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ABSTRACT
PART I: Mismatch repair in Gi synchronized mammalian cells 
Deficiencies in DNA mismatch repair have been found in hereditary nonpolyposis colon 
cancer (HNPCC), as well as in sporadic cancers, illustrating the importance o f this single 
repair system in maintaining genomic integrity. In bacteria, this repair system functions 
primarily, after DNA replication, in the correction of polymerase base insertion errors 
and in mammalian cells it was also assumed that the mismatch repair system functioned 
within a similar timeframe. However, DNA mismatches occur ubiquitously and their 
repair before DNA replication is of paramount importance for faithful genome copying. 
We investigated the activity of the mismatch repair system, in Gi synchronized NIH 3T3 
cells, in the repair of four mismatches at an oncogenic hotspot in the H-ras gene. Our 
results clearly show that the mismatch repair system is active and accurate during the pre- 
replicative Gi phase of the mammalian cell cycle
PART II: Effects o f  p,p ’-DDE on cell toxicity and DNA mismatch repair ability
Umbilical cord blood, from Inupiat infants in Barrow Alaska, was examined for the 
presence of several environmental contaminants. All 24 blood samples analyzed 
contained measurable levels of p,p'-DDE (1, l-dichloro-2,2-bis(p-chlorophenyl)ethylene) 
with an average concentration of 0.33 fa.g/1. We examined whether this low concentration 
of p,p’-DDE had detectable effects on NIH 3T3 (mouse embryonic) and WS1 (human 
fetal) cells in culture. Initial experiments indicated that exposure to p,p’-DDE resulted in 
a decrease in the cell number of both cell types. Subsequent analysis revealed that this
decrease was due to cell death in NIH 3T3 cells and to ceil cycle arrest in WS1 cells. We 
also examined the effect of p,p’-DDE on the ability of both cell types to repair 
mismatches at an oncogenic hotspot in H-ras. Preliminary results indicate that p,p’-DDE 
does not have a discemable effect on the ability o f either cell type to correctly repair the 
G:T mismatch. However, p,p’-DDE exposure results in an increased rate of correct repair 
of the G: A mismatch by both cell types. Overall, this study demonstrates that p,p’-DDE, 
at concentrations relevant to the Alaskan environment has significant but different effects 
on two immature cell types in culture.
5TABLE OF CONTENTS
Signature Page 1
Title Page 2
Abstract 3
Table o f Contents 5
List of Figures 12
List of Tables 13
Acknowledgements 14
I. INTRODUCTION 15
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized 
mammalian cells 15
A. Sources and implications of DNA damage 15
B Mechanisms ofDNA repair 21
(i) Damage reversal 21
(ii) Base excision repair 23
(iii) Nucleotide excision repair 28
(iv) Mismatch repair 33
(a) Mismatch repair in E. coli 33
(b) Mechanism of bacterial mismatch repair 34
(c) Eukaryotic mismatch repair 36
(d) Other proteins implicated in mismatch repair 42
(e) Mismatch repair and HNPCC 44
(f) Mismatch repair proteins participate in processes
other than mismatch repair 44
(g) Mismatch repair and the cell cycle 47
PARTII: Effects o f  p ,p ’-DDE on cell toxicity and mismatch repair ability
at an oncogenic hotspot 50
II. MATERIALS AND METHODS 55
A. Reagents 55
B. Cell lines and bacteria 55
C DNA 56
D. Enzymes 56
E Plasmid and M l3 constructs 56
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized 
mammalian cells 58
Section I: Method o f Gi synchronization, fluorescent activated cell sorting analysis, 
plasmid replication kinetics and mismatch repair protein expression in Gi nuclear 
extracts 5 8
A. Gi synchronization and fluorescent activated cell sorting analysis 58
B. Plasmid replication kinetics 59
(i) Transfection of Gi synchronized cells 59
7(ii) Plasmid recovery and digestion 60
(iii) DNA transfer and immobilization (Southern Blot) 60
(iv) Radioactive probe preparation 61
(v) Hybridization 62
C Mismatch repair protein expression in Gi nuclear extracts 63
(i) Gi nuclear extract preparation 63
(ii) Western blotting 64
Section II: Mismatch repair in the Gi phase o f  the mammalian cell cycle 66
A. Mismatch construction at codon 12 of H-ra.y 66
(i) Fragment preparation 66
(ii) Oligonucleotides 66
(iii) Melt and reanneal for site- and strand-specific mismatch
construction 67
(iv) Isolation of site- and strand-specific mismatch containing
1.8kb fragment 68
(v) Assembly o f the completed mismatch plasmid 68
B. Transfection of Gi synchronized NIH 3T3 cells and transformation of 
DH5a E. coli with mismatched plasmid 71
(i) Bacterial Transformation 71
(ii) Transfection of GI synchronized NIH 3T3 cells 71
C. Mismatch repair analysis 72
8(i) DNA extraction 72
(ii) PCR amplification 73
(iii) Contamination check o f amplified H-ra.s segment 74
(iv) Mismatch repair rate analysis 74
(v) Sequencing 77
PARTII: Effects o f  p ,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot 79
Section I: Preliminary experiments to investigate the toxicity o f environmental 
relevant concentrations o f  p,p '-DDE on two immature mammalian cell types 79
A. p,p’-DDE preparation 79
B. Short-term assays of chemical toxicity 79
(i) Assays for changes in cell number 79
(ii) Cell viability (Trypan Blue) assay 80
(iii) Assays for total glutathione (GSH + GSSG) and
reduced glutathione (GSH) 81
(iv) DNA damage assay 82
(v) Cell cycle kinetics assay 83
C. Long-term assays of chemical toxicity 84
(i) Colony forming ability 84
(ii) Transformation assay 85
(iii) Statistical analysis 85
9Section II: Effects o f  environmentally relevant concentrations o f p,p ’-DDE on 
mismatch repair at an oncogenic hotspot 86
A. Plasmid and M13 constructs 86
B. Mismatch construction 87
(i) Fragment preparation 87
(ii) Oligonucleotides 87
(iii) Melt and reanneal 87
(iv) Isolation of the 1.8 kb fragment 87
(v) Final assembly of the site- and strand-specific mismatched
pbc-Nl plasmid 87
C. Transfection of p,p'-DDE treated NIH 3T3 and W S1 cells
with mismatched plasmid 88
D. Mismatch repair analysis 89
(i) Cell harvest and plasmid extraction 89
(ii) Transformation of NR9374 mismatch repair
deficient bacteria 89
(iii) Mini-preparations and DNA extraction from
individual NR9374 colonies 90
(iv) PCR amplification 90
(v) Contamination check of amplified H-rav segment 91
(vi) Mismatch repair analysis 91
(vii) Sequencing 91
10
UI. RESULTS 92
PART I: Mismatch repair at an oncogenic hotspot in Gt synchronized 
mammalian cells 92
Section I: Gi synchronization, fluorescent activated cell-sorting, plasmid replication 
kinetics and mismatch repair protein expression in G\ nuclear extracts 92
A. Gi synchronization and fluorescent activated cell sorting analysis 
(FACS) 92
B. Plasmid replication kinetics 94
C. Mismatch repair protein expression in Gi nuclear extracts 96
Section II: Mismatch repair in the GI phase o f the mammalian cell cycle 99
A. Mismatch repair rates at codon 12 of W-ras in Gi synchronized
mammalian cells 99
PARTII: Effects o f  p ,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot 104
Section I: Preliminary experiments to investigate the toxicity o f  environmentally 
relevant concentrations o f  p,p '-DDE on two immature mammalian cell types 104
A. Short-term assays of chemical toxicity 104
(i) Assays for changes in cell number 104
(ii) Cell viability (Trypan Blue) assay 107
(iii) Assays for total glutathione (GSH + GSSG) and
11
reduced glutathione (GSH) 107
(iv) DNA damage assay 113
(v) Cell cycle kinetics assay 116
B. Long-term assays o f chemical toxicity 119
(i) Colony forming ability 119
(ii) Transformation assay 119
Section II: Effects o f environmentally relevant concentrations o f  p,p ’-DDE
on mismatch repair at an oncogenic hotspot 120
A. Mismatch repair rates at codon 12 of H-ras in the presence
of p,p’-DDE 120
IV. DISCUSSION 124
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized 
NIH 3 T3 cells 124
PART II: Effects o f  p,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot 131
V. REFERENCES 142
12
LIST OF FIGURES Page
1. Human base excision repair 27
2. Human nucleotide excision repair 32
3. Model for mismatch repair in E.coli 35
4. Human mismatch repair; proposed interactions of
human mismatch repair proteins 41
5. Mismatch plasmid construction 70
6. Mismatch repair analysis 75
7. Mismatch repair analysis; example of a polyacrylamide sequencing
gel autoradiograph 78
8. Plasmid replication kinetics 95
9. Western blot of NIH 3T3 Gi nuclear and cytoplasmic extracts 98
10 Comparison of mismatch repair rates in Gi synchronized and non­
synchronized NIH 3T3 cells 103
11. Assay for changes in cell number 106
12. Assays for total glutathione (GSSG + GSH) and
reduced glutathione (GSH) 111
13. Comet assay 114
14. Cell cycle kinetics assay 117
15. Colony forming ability 118
13
LIST OF TABLES page
Table 1. Human DNA glycosylases and the damage they repair 24
Table 2. Mut homologs in yeast and humans 37
Table 3. Percentage of NIH 3T3 cells in the Gi phase of the cell cycle
with and without serum starvation 93
Table 4. Mismatch repair at codon 12 of H-ras in Gi synchronized
NIH 3T3 cells 101
Table 5 Mismatch repair at codon 12 of H-ras in DH5a E.coli 102
Table 6 Assay of cell viability (Trypan Blue) 108
Table 7. DNA damage assay (Comet assay) 115
Table 8. Mismatch repair at codon 12 of H-ras in p,p’-DDE
treated and untreated WS1 cells 121
Table 9 Mismatch repair at codon 12 of W-ras in p,p’-DDE
treated and untreated NIH 3T3 cells 123
ACKNOWLEDGEMENTS
Thanks to everyone who have helped me get through this long process; Dr. Kandace 
Williams, Dr Larry Duffy, Dr. Kelly Drew, Dr Lynne Lucher, Dr. Nancy Matton and 
Ileana Bembeneck.
And you John who made it all possible, thanks for sticking with me, without your love 
and support I would not have gotten this far.
I. INTRODUCTION
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized mammalian 
cells
A. Sources and implications o f  DNA damage
The primary function of DNA is the passage of unaltered genetic information from one 
generation to the next and it has been primarily for this reason that DNA has traditionally 
been assumed to be a very stable and static molecule. However, as we now know, DNA 
is subject to a constant barrage of damaging insults originating from many endogenous 
and exogenous sources (Reviewed in 1, 2). Furthermore any damage left unrepaired will 
be fixed permanently in the genome as a mutation following DNA replication. Because 
specific mutations are the primary cause of genetic disease, it follows that understanding 
the origin of mutations is essential to understanding the etiology o f cancer and heritable 
human diseases.
Exogenous damage can arise from both physical and chemical origins. An 
important source of physical damage is UV radiation, which causes adjacent pyrimidines 
to become covalently linked to form helix distorting cyclobutane pyrimidine dimers and 
6-4 photoproducts (2). Similarly, exposure to ionizing radiation produces modified bases 
such as thymine glycol as well as causing DNA single and double strand breaks (3).
Chemical sources o f DNA damage are numerous but can be grouped into several 
categories, including the alkylating agents, the cross-linking agents, such as cisplatin and 
finally, the largest group which consists of those compounds requiring metabolic 
activation e.g. aflatoxin. These chemicals interact with DNA in various ways and cause
numerous types of lesions including abasic sites, DNA interstrand linkages and base 
modifications (4, 5, 6).
However, on a daily basis, it is normal cellular processes that cause the majority 
of damage to DNA. Nucleotide bonding rearrangements or tautomeric shifts can cause 
base misincorporation during DNA replication. Deamination of cytosine, adenine, 
guanine and 5-methlycytosine occurs in the normal cellular environment and the resulting 
products are miscoding lesions, for example, cytosine deaminates to uracil, which if not 
repaired will result in a G.C —» A T transition during replication. In addition. DNA 
undergoes spontaneous depurination and depyrimidination events culuminating in the 
appearance of abasic, or apurinic/apyrimidinic (AP) sites, with miscoding potential (7). In 
fact, AP sites originate from so many sources that they are reported to be the most 
abundant DNA lesion in living cells (8).
Oxidative damage to DNA, by reactive oxygen species, is considered to be 
another major source of endogenous damage. The primary sources of reactive oxygen 
species are the mitochondria, which leak oxygen radicals during aerobic metabolism (9,
10). DNA lesions, which result from oxidative damage, include fragmentation, base loss, 
strand breaks and nucleotide modifications such as thymine glycol and 8-hydroxyguanine 
(9, 10, 11).
Misincorporation of non-complementary bases during DNA replication is another 
major source of pro-mutagenic base pairing errors. The human genome is composed of 3 
x 109 base pairs and undergoes one cycle of replication per day in a typical proliferating 
cell (12). The polymerases responsible for DNA replication have variable rates of base
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misincorporation (13). For example, DNA polymerase (3, the enzyme responsible for the 
synthesis of short segments of DNA during repair has an error rate of 1 in 5000, while the 
DNA polymerases 5 and s, both of which have an intrinsic 3 ’ -  5’ exonucleolytic 
activity, have an error rate of 1 in 10,000,000 (Reviewed in 14, 15, 16).
It is estimated that the total number o f potentially mutagenic DNA damaging 
events resulting from spontaneous depurination, oxidative modification, non-oxidative 
base alterations and replication errors is on the order of 100,000 DNA damaging events 
per day per cell (17). Thankfully, before any o f that DNA damage can be fixed in the 
genome as a mutation it will most likely be repaired by one o f the following repair 
systems (i) damage reversal, (ii) Base excision repair, (iii) Nucleotide excision repair, and
(iv) Mismatch repair (Reviewed in 18). In fact, the combined repair systems are so 
efficient that the estimated occurrence of mutations within a normal proliferating cell has 
been reported to be as low as 1.4 x 10~10 mutations/nucleotide/cell generation (19).
One o f the hallmarks of cancer is the presence of multiple mutations within the 
same cell, even thousands in highly transformed cells (16). However, due to the 
efficiency of the various DNA repair systems, the normal cellular mutation rate is much 
too low to account for this amount o f mutation accumulation and has led to the 
hypothesis that genetic instability or a “mutator phenotype” is an early event in cancer 
development (19, 20). The mutator phenotype hypothesis proposes that genes involved in 
maintaining chromosomal stability (e.g. tumor suppressor genes, DNA repair genes) are 
mutated early in tumor progression, thus permitting an enhanced rate of mutation that 
eventually leads to the development of cancer (21).
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The greatest evidence for the existence of a mutator phenotype came with the 
discovery that DNA from the tumors o f patients with hereditary non-polyposis colon 
cancer (HNPCC) exhibited microsatellite instability (Reviewed in 22). Microsatellites are 
repetitive nucleotide sequences whose lengths are relatively constant in normal cells but 
vary in tumor cells. It was discovered that this microsatellite instability in HNPCC 
occurred in tandem with defects in the mismatch repair pathway (23, 24). When human 
homologs of the bacterial and yeast mismatch repair genes were identified, genetic 
linkage analysis revealed that the location of each gene correlated with the location of the 
genes mutated in HNPCC cells (25, 26). For the first time a direct link was discovered 
between the development of cancer and inactivation of some of the genes responsible for 
maintaining genomic integrity. Microsatellite instability and the corresponding 
inactivation o f one or more mismatch repair genes has since been discovered in a large 
number of tumors not associated with HNPCC and is proposed to be an important factor 
in the development of several sporadic cancers (16, 27, 28, 29).
Carcinogenesis, or malignant transformation, is a stepwise process characterized 
by the accumulation of multiple genetic alterations in critical genes such as proto­
oncogenes and tumor suppressor genes and culminates in the appearance of a population 
of cells that can evade the normal cellular restraints on proliferation, differentiation, 
mobility and death (16). During the 1960’s it was discovered that mutations induced in 
the DNA of bacteriophages were not randomly distributed but rather were focused at 
specific sites along the genome (30) and more recently in human cells, an examination of 
the mutational spectra induced by MNNG (N-methyl-N’-nitro-N-nitrosoguanidine) in the
HPRT gene found that only a small percentage o f the potential number of damaged base 
sites were actually mutated (31). A site at which the frequency or rate of mutation 
exceeds that at other sites is called a “hotspot of mutation” and in fact current consensus 
is that the majority of human gene mutations are found at hotspots (32).
Prime examples o f “mutational hotspots” are found in the genes of the ras family. 
Mutations in N, K and H-ras have been observed in various naturally occurring human 
tumors as well as carcinogen-induced animal tumors. As well, the transforming ras genes 
have been shown to be mutant alleles of cellular ras genes that are transformed by a 
single point mutation within their coding regions. Direct sequence analysis has 
demonstrated that there are activating mutations in the ras oncogene family in nearly 30% 
of human tumors. Furthermore, these mutations have been localized most frequently to 
codons 12, 13 and 61 (34, 35, 36, 37, 38, 39).
H-ra.v belongs to a family of genes that encode small GTP binding proteins. These 
proteins function as molecular switches and are active in their GTP-bound form and 
inactive in their GDP-bound form. The Ras proteins are part o f a complex cellular 
transduction pathway that transmits external control signals for proliferation, 
differentiation and apoptosis from the plasma membrane to the nucleus via multiple 
effector proteins (33, 36, 37, 38, 40). Moreover, protein products of the mutated genes 
remain activated regardless of up-stream regulators (41).
Currently, there is not a definitive explanation as to why particular gene locations 
are “mutational hotspots” but several hypotheses have been put forward to explain them 
(42). The first hypothesis is that activating mutations are selected for due to the increased
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survival rates that they confer. Although this explanation may seem plausible it does not 
explain why only some activation sites are found mutated in human tumors. For example, 
in H-ras there are several sites, in addition to codons 12, 13 and 61, which have been 
found to be activating mutations in vitro but have never been found in human tumors or 
animal model studies (36, 37, 38, 39). It follows, that since all activating mutations 
confer a similar survival advantage they should all be found with equal probability in 
tumors, but since this is not the case this hypothesis does not sufficiently explain 
mutational hotspots.
The second hypothesis proposes that certain DNA sequences are more susceptible 
than others to mutation. A number of studies both in vivo and in vitro have found that 
precise mutagen targeting does occur and numerous animal studies have demonstrated 
correlations between type of mutagen, location and resulting activating ras mutation (35, 
36, 37, 43). In addition several studies have shown preferential carcinogen binding at 
mutational hotspots in the p53 tumor suppressor gene (44, 45). It is clear from this 
evidence that chemically induced mutations are targeted to specific DNA sequences.
The third hypothesis, proposed to explain mutational hotspots, states that there is 
decreased fidelity of repair or inefficient repair at particular DNA sequences For 
example, nucleotide excision repair of pyrimidine dimers and benzopyrene adducts has 
been shown to occur correctly but more slowly at mutational hotspots in the p53 tumor 
suppressor gene (46, 47, 48).
As well, results, from studies examining the repair of inserted guanine adducts at 
different positions in H-ra.v (49, 50, 51) and the repair of UV induced lesions in the SupF
gene of an SV40 vector in Hela cells (52) have found that repair rates vary at different 
locations. In addition, previous work in this laboratory has shown that, depending on the 
specific base:base mispair, there is decreased fidelity of mismatch repair at the middle 
base pair position of codon 12 of H-ras (53). Moreover, further studies have shown that 
the same mismatches at codon 10, (which has the same sequence as codon 12 but is not a 
hotspot of mutation), have an improved rate o f repair as compared to codon 12 (54). 
These studies demonstrate that specific DNA locations containing specific DNA lesions 
have decreased efficiency of repair and likely contribute to the occurrence of “mutational 
hotspots” Of course, the above hypotheses are not mutually exclusive and hotspots may 
occur due to a combination of these factors and/or other contributing events, which have 
not yet been determined.
B. Mechanisms o f DNA repair
(i) Damage reversal
The simplest repair of DNA damage is to remove or reverse the lesion in a one-step 
reaction thus restoring the genome to its normal structure. The simplest direct reversal 
process is carried out by DNA Ligase I and involves rejoining the ends of a single strand 
break (55). However, this type of repair occurs only when the process that caused the 
break has not modified the strand ends (2).
Photo-reactivation is an additional repair mechanism that reverses DNA damage 
and is found primarily in yeast and bacteria. This system functions to remove UV lesions 
from cellular DNA Photolyase, the enzyme involved in this process reverses cyclobutane
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pyrimidine dimers to their parental monomers using visible light as an energy source 
(Reviewed in 56 ). The enzyme activity has been detected in a wide variety of organisms 
ranging from bacteria to non-placental mammals (57). However, the evidence for photo­
reactivation in placental mammals is still hotly debated with no clear consensus as to the 
presence, absence or activity of this DNA repair mechanism (57, 58, 59, 60, 61, 62, 63).
In contrast, homologs of the direct repair “suicidal” alkylating enzymes have been 
found in many prokaryotic and eukaryotic organisms including humans. The 
alkyltransferase enzymes function to remove alkylation damage that results from 
exposure to either exogenous alkylating agents or cellular catabolites acting as 
monofuntional alkylating agents (2, 64, 65). For example, the 0 6-methylguanine lesion 
miscodes for the incorporation of thymine instead o f cytosine during replication and 
results in a G:C to A:T transition mutation. The alkyltransferase enzyme O6- 
methlyguanine DNA methyltransferase, or MGMT, removes the methyl group from the 
O6 lesion and transfers it to one of its own cysteine residues returning the base to its 
unmodified state and methylating the enzyme (Reviewed in 56, 66). Finally, since the 
methylated enzyme cannot be recycled it is degraded by the ubiquitin proteolytic pathway 
(67). This repair mechanism appears extremely inefficient since it removes only one 
lesion at the expense of an entire protein molecule when other, less costly multifunctional 
repair mechanisms are present in the cell . However, these one-step enzymes may have 
been retained because their repair of the DNA lesion occurs rapidly and efficiently 
relative to the other DNA repair mechanisms and are error free (63).
(ii) Base excision repair
Base excision repair (BER) is the major mechanism that replaces damaged bases with 
relatively minor modifications such as deoxyuracil, thymine glycol and 8-oxo-guanine 
(8). BER is performed in two stages: an initial damage recognition and removal stage 
carried out by individual DNA glycosylases targeted to specific base lesions and a 
general repair stage that restores the correct DNA base sequence (68).
DNA glycosylases are grouped into two distinct categories (i) monofunctional 
DNA glycosylases that remove the altered base 5’ to the damage without cleaving the 
sugar-phosphate backbone and, (ii) bifunctional DNA glycosylases which remove the 
damaged base but also have an additional intrinsic AP lyase activity that cleaves at the 3’ 
side of the damaged base leaving behind an incised AP site. Table 1 contains examples of 
human DNA glycosylases and the DNA damage that they repair (Reviewed in 2 and 
references indicated).
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Table 1 :Human DNA glycosylases and the damage they repair
NAME Example of 
damaged removed
Mono- or 
Bifunctional
Reference
Uracil DNA 
glycosylase
Uracil due to 
cytosine 
deamination or base 
mis-incorporation
mono 69, 70, 71, 72
Thymine DNA 
glycosylase
Thymine from G:T, 
uracil from G:U 
mismatches
mono 73, 74, 75, 76
Mut Y adenine 
glycosylase
Removes adenine 
from A C or G:A 
mismatches
Reported as both 68, 77, 78. 79
hNTHI DNA 
glycosylase.
Thymine glycol, 
(removes oxidized 
pyrimidines)
bi 71, 80
hOGGl s-OG:C mono 81
Both types of glycosylase recognize and remove base damage by the same 
nucleotide flipping mechanism. Using this method the enzyme flips out the damaged base 
from the DNA helix into the enzyme’s active site where breakage o f the N-glycosvi bond 
linking the damaged base to the sugar-phosphate backbone occurs, creating an 
apurinic/apyrimidinic (AP) site (68). If the glycosylase is monofunctional a physically 
distinct AP endonuclease incises the sugar-phosphate backbone. On the other hand if the 
glycosylase is bifunctional its intrinsic AP lyase activity performs the incision step.
Repair of the resulting AP sites can proceed by two pathways -  a DNA polymerase (3- 
dependent pathway (Short-patch BER) and a proliferating cell nuclear antigen (PCNA)- 
dependent pathway (Long-patch BER) (71, 82, 83, 84).
Short-patch BER involves the removal of a single damaged base followed by its 
replacement via a series of enzymatic steps. This process has been reconstituted in vitro 
with the purified human proteins; uracil DNA glycosylase, AP endonuclease (HAP 
1/APE), DNA polymerase (3, and either DNA Ligase I or DNA ligaselll + XRCC1, (85, 
86). For example, uracil, which occurs in DNA as a result of cytosine deamination or 
uracil mis-incorporation during DNA replication, is excised by uracil DNA glycosylase 
to create an AP site. The human AP endonuclease HAP 1/APE then hydrolyzes the DNA 
backbone generating 3’-hydroxyl and 5’-deoxyribose phosphate (dRP) ends. The dRP 
group is excised by the dRP lyase component of DNA polymerase P, producing a single 
nucleotide gap with 3’-hydroxyl and 5’-phosphate ends. DNA polymerase P fills in the 
gap, a DNA ligase seals the nick and the normal sequence of the DNA is restored (87) 
(Figure 1A). The exact role of XRCC1 is uncertain but it may act as a scaffolding protein 
and recruit and position other components of the repair process (86). Short-patch BER by 
the bifunctional glycosylases e.g. human 8-oxoguanine DNA glycosylase (hOGGl) 
occurs via the same mechanism except that the incised AP site requires additional 
processing by the HAP 1/APE endonuclease before repair can proceed (80).
Long-patch BER involves the gap filling of several nucleotides. Recently, purified 
HAP 1/APE, PCNA (proliferating cell nuclear antigen), RF-C (Protein replication factor 
C), FEN1, DNA polymerase 5 or e and DNA ligase I were shown to be required for 
efficient long patch BER at an in vitro AP site (8, 88) (Figure IB). However, it is still 
unclear as to the exact role of each of these proteins in the repair pathway. PCNA appears 
to act as a molecular adaptor that brings together the protein units necessary to repair the
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incorporation
AP Endonuclease 
(HAP 1 /APE)
5’Nick
J f
dRP Lyase activity of 
DNA polymerase P
S ingle  nuc leo t id e  gap
DNA polymerase P 
DNA Ligase III + XRCCI
AP Lyase activity of bi-functional 
DNA glycosylase
3’Nick
5 - \L
PCNA, RF-C 
FEN1
2-6  nucleo t ide  gap
DNA polymerase 5/s 
PCNA, RF-C 
DNA Ligase I
Repaired strand Repaired strand
Figure I:Human Base Excision Repair
A: Short-patch BER, B: Long-patch BER 
See text for description of processes.
Figure adapted from Krokan et al 1997 (71).
(iii) Nucleotide Excision Repair (NER)
A direct correlation between unrepaired DNA damage and carcinogenesis in humans was 
first established when it was discovered that the cancer prone hereditary disease 
xeroderma pigmentosum (XP) involved a defect in the repair of DNA lesions produced 
by UV light (90). In humans the primary mechanism for the repair of DNA produced by 
UV light is nucleotide excision repair (NER) (56, 91, 92, 93).
XP is clinically characterized by extreme photosensitivity, pigmentation 
abnormalities in sun exposed skin, mental retardation and other neurological 
abnormalities (Reviewed in 94). XP patients have a greater than 1000-fold increased risk 
of developing sun-exposed skin cancers, particularly basal cell carcinomas and melanoma 
and a 10- to 20- fold increased risk of developing several types of internal cancers under 
the age of 20 years. Seven complementation groups have been identified in XP patients 
and are designated XPA through XPG. Each group designation represents a defect in a 
specific NER gene that essentially inactivates the repair process. In addition, an eighth 
XP complementation group was identified and designated XPV, or variant form, and was 
found not to be defective in NER, but instead lacks a mechanism to bypass DNA damage 
during replication.
Nucleotide excision repair (NER) has the capacity to repair many different types 
of DNA lesions. However, in order for a lesion to be a substrate for NER it must cause 
both a distortion of the helix as well as chemically modifying the DNA. Pyrimidine 
dimers, such as those induced by UV light and the bulky adduct damage caused by
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chemicals such as cisplatin, benzpyrene and aflatoxin are typical o f the types of damage 
repaired by the nucleotide excision repair system (Reviewed in 93).
Nucleotide excision repair has been reconstituted in vitro with purified human 
proteins and involves approximately 2 0 -3 0  polypeptides and occurs in four sequential 
steps (Figure 2) (96).
(1) Damage recognition. Sugasawa et al have established that, in NER, a protein 
complex consisting o f XPC and hHR23B is responsible for initial damage recognition 
and subsequent recruitment of the remaining repair proteins to the damage site (95). 
However, it has been found that a complex consisting of XPA and RPA also performs a 
damage recognition function (93). Although the debate continues, recent evidence 
suggests that the damage type and the helix distortion it causes may determine the protein 
complex that recognizes it (97).
(2) Dual incision: In order for dual incision to occur on either side of the lesion, a 
complex consisting of XPC/hHR23B, XPA, RPA and TFIIH first binds to the damage 
site and causes an area of the helix to unwind. Full unwinding o f the helix around the 
lesion requires ATP, which is provided by the XPB and XPD protein subunits of TFIIH. 
and results in the creation of cutting sites for the endonucleases XPG and ERCC1/XPF 
XPG cuts at the 3’ side of the open complex and the ERCCI/XPF complex cuts at the 
single-strand to double-strand transition 5’ to the damage. Their combined actions 
cumulate in the excision of a single-stranded oligonucleotide 24-32 nucleotides in length 
containing the damage.
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( 3 - 4 )  DNA resynthesis and ligation: Finally, re-synthesis and ligation of the 
excised patch is carried out by RPA, RF-C, PCNA, DNA polymerase 5 or e and DNA 
Ligase I, thus restoring the DNA to its normal structure.
As is the case with base excision repair there are also two types o f nucleotide 
excision repair. The process described above is designated global genome nucleotide 
excision repair (GG-NER) and as the name suggests, removes DNA damage from any 
place in the genome. In addition, a specific type of NER exists for active genes, in which 
the transcribed strand is repaired 5 to 10 times faster than the non-transcribed strand, and 
is referred to as transcription-coupled nucleotide excision repair (TC-NER) (98, 99. 100, 
101). The mechanism of TC-NER is essentially the same as that for GG-NER except that 
during transcription the arrest of RNA polymerase II at the site of a lesion is thought to 
serve as an alternate recognition signal that then recruits the remaining repair proteins to 
the damage site (Reviewed in 102, 93).
Two diseases, Cockayne's syndrome (CS) (characterized by skeletal 
abnormalities, mental retardation, photosensitivity and shortened lifespan) and 
trichothiodystophy (TTD) (characterized by photosensitivity, short stature, brittle hair 
and shortened lifespan) are caused by defects in transcription-coupled NER (91, 94) 
Interestingly, a concomitant increase in cancer development is not associated with either 
disease and may be due to the retained capacity to carry out global genome NER (99) 
However, it must also be noted that both of these diseases are associated with a 
significantly shortenened lifespan, which in and of itself may explain the absence of an 
increased incidence of cancer, a long-term complication in these patients.
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Although, the precise roles of each of the proteins participating in NER is not yet 
understood, recent studies have begun to elucidate some possible functions. For example, 
in addition to its role in the re-synthesis o f the excised DNA tract, the single stranded 
binding protein RPA may serve to orientate the XPG and XPF/ERCC1 exonucleases to 
their respective 3’ and 5’ incision sites, (103). In fact, the plethora of proteins involved in 
this repair process has made it apparent to researchers that NER is an extremely complex 
and important repair pathway and that much more research is needed to fully understand
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Figure 2: Human Nucleotide Excision Repair
Adapted from Mol et al 1999 (68)
See text for description of process
Since the discovery that hereditary non-polyposis colorectal cancer (HNPCC) is caused 
by inherited mutations in genes involved in mismatch repair there has been extensive 
study towards understanding how this human DNA repair mechanism functions. In 
general two types o f base mis-pairing occur in DNA. The first occurs when non- 
complementary bases are mistakenly paired together and are not removed by proof­
reading mechanisms during DNA replication. The second type of pairing error arises as a 
consequence of misalignment of the two DNA strands and, depending on the extent of 
misalignment, results in the formation of single-stranded loops of one or more bases in 
the DNA duplex which are termed insertion/deletion loops (IDLs). Base-base mismatches 
and IDLs can arise by a number of processes including, and perhaps most importantly, 
nucleotide misincorporation errors during DNA replication (17).
(a) Mismatch repair in E. coli.
In bacteria mismatch repair is a post-replicative DNA repair mechanism, which relies on 
the hemi-methylation state of newly replicated DNA to target repair to the nascent strand 
(2, 105, 107, 109, 141). Current knowledge of bacterial mismatch repair is that it involves 
ten components that can be separated into two groups. Group 1 is comprised of proteins 
that function primarily in DNA repair: MutS, MutL and MutH. Group 2 contains proteins 
that also function in other pathways of DNA metabolism: MutU (Helicasell/UvrD), SSB 
(single stranded binding protein), DNA Ligase. DNA polymerase III holoenzyme and the 
DNA endonucleases (RecJ, Exo VII, Exo I and Exo X).
(iv) Mismatch repair
S tep l. The ATPase MutS binds to the mismatch as a homodimer (110). Step 2. MutS 
recruits MutL and MutH to the repair site where the DNA is manipulated into a loop 
structure termed an a-loop (111). Step 3: The MutS, L and H proteins attach to the base 
of the a-loop and proceed to translocate along the DNA. This movement is dependent on 
ATP hydrolysis and is presumed to function as a searching mechanism for the strand 
discrimination signal, which in bacteria is the brief post-replication hemi-methylation 
state of the DNA (parent strand methylated, daughter strand containing incorrect base 
remains unmethylated for a short period following replication). MutS is primarily 
responsible for ATP hydrolysis but MutL has recently been shown to also be necessary 
for that activity (112, 113). Step 4: MutH is activated by MutL to cleave the daughter 
strand at the nearest unmethylated GATC site to the damage. Step 5: MutL loads MutU 
(Helicase II/UvrD) onto the DNA in the correct orientation at the MutH nicked site where 
it proceeds to unwind the duplex DNA towards the mismatch (114, 115). Step 6 : The 
displaced single-stranded DNA containing the mismatch is degraded by any one of the 
four endonucleases (RecJ, Exo VII, Exo I or Exo X) (107, 116), the resulting single 
stranded gap is stabilized by SSB protein filled in by DNA polymerase III holoenzyme 
and finally sealed by DNA ligase (107) (Figure 3).
(b) Mechanism o f bacterial mismatch repair:
Base: Base Mispair 
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Figure 3: Model for mismatch repair in E.coli
see text for description of mechanism 
Adapted from Dao and Modrich 1998 (106)
The importance of mismatch repair is reflected by its conservation in organisms as 
diverse as bacteria and humans. In fact, homologues of the bacterial MutS and MutL 
proteins have been found in nearly all organisms examined (107). However, two 
important differences exist between bacterial and eukaryotic mismatch repair. The first is 
that in bacteria the strand discrimination signal is provided by the hemi-methylation state 
of the newly replicated DNA but in eukaryotic cells this signal does not exist. Secondly, 
in bacteria the proteins involved in the individual steps function as homodimers but in 
eukaryotes they function primarily as heterodimers.
Thus far six MutS homologs have been identified in eukaryotes (MSH 1-6) of 
which five have been identified in humans (hMSH2-6) (Table 2). Mshl is required for 
normal mitochondrial function in yeast but as yet no mammalian homologs have been 
reported (117. 118), The most recently identified human MutS homologs are hMSH4 and 
hMSH5. Both of these proteins are expressed only in tissue actively engaged in meiosis 
where they are found as a heterodimer (119). However, their protein complex does not 
appear to participate in mismatch repair but may play a role in meiotic recombination 
(120). In contrast, the remaining human MutS homologs; hMSH2, hMSH3 and hMSH6, 
have all been shown to participate in mismatch repair and are discussed below.
(c) Eukaryotic mismatch repair
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Table 2: Mut homologs in yeast and humans (from 118)
E. coli S.ccrevisiae H. sapiens
MutS Msh2, Msh6, Msh3 hMSH2, hMSH3, hMSH6
Mshl Not identified
Msh4, Msh5 hMSH4, hMSH5
MutL Mlhl hMLHl
Pmsl hPMS2
Mlh2, Mlh3 hPMSl, hMLH3
MutH Not identified Not identified
MutU (Helicasell/UvrD) Not identified Not identified
Both hMSH2 and hMSH6 contain a conserved “Walker Type A” nucleotide- 
binding fold (121) and together form the hMutSa heterodimer. hMutSa restores DNA 
mismatch repair to tumor cells, binds to and initiates repair o f base-base mispairs (122) 
and, although it has been reported to repair IDL’s containing up to 12 unpaired bases, 
functions primarily in the repair of IDL’s containing one inserted base (123, 124) The 
hMutSa heterodimer possesses an intrinsic ATPase activity, which is consistent with the 
presence of the “Walker Type A” nucleotide-binding fold (125). The ATPase is 
stimulated by the presence of mismatched DNA and has been found to be dispensable for 
mismatch binding but necessary for mismatch repair in vitro (125). There now appears to 
be a general consensus in the literature that mismatched DNA stimulates ATP hydrolysis 
in mismatch repair (126, 127) However, there is substantial dissent regarding the role of
ATP hydrolysis in mismatch repair (128, 129, 130). Two models have been proposed to 
explain the purpose of the interaction between hMutSa and ATP. The first proposes that 
upon binding the mismatched DNA, hMutSa undergoes an ATP-hydrolysis dependent 
translocation along the DNA backbone. The translocation then functions as a signal to the 
other components of mismatch repair as well as exposing the site o f mismatch to them 
(130).
The second ATP interaction model proposes that hM utSa exists primarily in an 
ADP bound form. Binding of mismatched DNA provokes an ADP —» ATP exchange and 
results in the formation o f an ATP-bound sliding clamp that can diffuse along the DNA 
backbone and signal to the other components of mismatch repair (128, 129). In this 
Molecular Switch model hM utSa is “on” in the ADP bound form and “off’ in the ATP- 
bound form. This model proposes that ATP hydrolysis is not necessary for translocation 
but plays a role in the recycling of the ADP-bound hM utSa complex (126). Further 
evidence in support of this model is that the rate limiting step in the initiation of hMutSa 
mediated mismatch repair is the ability of particular mispaired bases to invoke the ADP 
—> ATP exchange reaction and has been linked to the efficiency of repair in vitro (131). 
Although, the debate continues as to the exact consequences of ATP and hMutSa 
interaction it is clear that ATP binding results in a conformational change in the protein 
complex that affects subsequent steps in the repair process.
The remaining MutS homolog, hMSH3 also possesses a “Walker Type A” 
nucleotide-binding fold (121) and together with hMSH2 forms the hMutS(3 heterodimer.
hMutSP supports the repair of IDL’s having 2 or more unpaired bases but does not 
participate in the repair of single base-base mispairs or IDL’s with less than two 
mispaired bases (120). In addition hMutSfi is reported to function as an ADP —> ATP 
molecular switch in a manner similar to hMutSa (132).
It has recently been established that the hMSH6 subunit is responsible for 
mismatch recognition, binding and the ATPase activity of hM utSa (134). Furthermore, a 
mutation in the hMSH6 ATPase site disables the hMutSa sliding clamp and prevents 
translocation along the DNA (133). These findings highlight the importance of the 
hMSH6 subunit and also imply similar functions for the hMSH3 subunit o f hMutSp. 
However, the importance o f hMSH6 and hMSH3 in the repair activity o f hM utSa and 
hMutSP is not reflected in the number of HNPCC kindred presenting with mutations in 
either gene. In fact mutations in either gene are rare in HNPCC (108, 135). This genetic 
evidence may be explained by a functional redundancy of these proteins whereby lack of 
either hMSH6 or hMSH3 is compensated for by the overlapping function of the 
remaining protein when it is complexed to hMSH2 (136).
Multiple MutL homologs have been identified in eukaryotic cells. As with MutS 
the human MutL homologs hMLHl, hPMS2 and hPMSl interact to form the 
heterodimers hMutLa (hMLHl and hPMS2) and hMutLP (hMLHl and hPM Sl) (137,
138, 139). Recently, a third human MutL homolog named hMLH3 has been identified 
(140). hMLH3 is a homolog of the yeast Mlh3 protein. Mlh3 forms a heterodimer with 
Mlhl and participates in the repair of IDL’s and it has been suggested that hMLH3 may 
play a similar role in human mismatch repair (141). Genetic and protein-protein
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interaction experiments have led to the proposal of a model for eukaryotic mismatch 
repair in which a heterodimeric complex o f either hMutLa or p interacts with either 
hM utSa or 3 during their ATP dependent/independent translocation along the DNA 
backbone from either a mispaired base or an insertion deletion loop (Figure 4). At this 
time little more is known about these interactions except that they involve ATP and the 
recruitment of other repair proteins.
41
V
')  hMSH6
hMutSa
V
hMSH3
^C'C'Os^C's''- \  \  \
hMutSP
Base: Base Mispair
(a)
Insertion/Deletion Mispair
(b)
Figure 4: Human mismatch repair
Proposed interaction of human mismatch repair proteins
(a) hM utSa recognizes and binds to mispaired bases and recruits 
hM utLa to the repair site
(b) hMutSP recognizes and binds to insertion/deletion mispairs and 
recruits the hMLHl/hMLH3 heterodimer to the repair site 
Adapted from Jirincy 1998 (108)
(d) Other proteins implicated in mismatch repair
PCNA (proliferating cell nuclear antigen) has been shown to be required at an early step 
in mismatch repair that precedes excision of the mismatch (142) as well as for the DNA 
resynthesis step that follows mismatch excision (143). In addition PCNA can be co- 
immunoprecipitated with hMSH2, hMSH6, hMLHl and hPMS2 (144, unpublished 
results from Williams laboratory 2001). A recent study has identified PCNA binding 
motifs in Msh3 and Msh6 and has shown that PCNA interacts with these proteins but not 
Msh2. As well, elevated mutation rates have been found in yeast when the PCNA binding 
motifs of these proteins are mutated and the authors suggest that the inability to bind 
PCNA may reflect reduced repair of mismatches recognized by the Msh2: Msh3 and 
Msh2: Msh6 heterodimers (145).
As yet no mechanism for strand discrimination has been identified in eukaryotic 
cells and no MutH homologs have been found. In vitro experiments have found that 
mismatch repair is directed to the DNA strand which contains a strand-specific and site- 
specific introduced nick and has raised the possibility that strand discontinuities flag the 
nascent DNA strand for mismatch repair (146, 147). As well, the involvement of PCNA 
in mismatch repair together with its functions in DNA replication has lead some 
researchers to conclude that PCNA acts to link the mismatch repair complex to DNA 
polymerase at the replication fork and in so doing facilitates recognition and repair of the 
nascent strand (142). However, this does not explain how mismatch repair functions in 
nonreplicating cells (139)
Genetic studies in yeast have found three endonuclease activities in mismatch 
repair: Exol and the proofreading exonucleases of DNA polymerases 5 and s (148) 
Exonuclease I  is a 5’ —» 3’ exonuclease that has a preference for degrading double­
stranded DNA and it is proposed that, in eukaryotes, its presence may eliminate the need 
for a DNA helicase in the 5’ —> 3’ degradation step (149). In yeast E xol interacts with 
Msh2 and its disruption leads to a weak mutator phenotype (150). Recently a human Exol 
homolog (hEXOl HEX!) has been identified and it has also been found to interact with 
hMSH2 (150, 151).
The exonuclease FEN 1 (RAD27 in yeast) has been implicated in mismatch repair 
due, in part, to its interaction with PCNA and because its mutation in yeast causes a small 
increase in frameshift mutations similar to those seen in mismatch defective mutants 
(153). However it remains to be determined why so many, seemingly redundant, 
exonucleases are functional in mismatch repair. As well it has been shown that DNA 
polymerase 5 (158) and the single stranded DNA binding protein RPA are required in 
eukaryotic mismatch repair (159). Although considerable progress has been made in 
identifying and understanding the proteins that function in mismatch repair it is apparent 
that many questions, ranging from the identification of the strand discrimination signal to 
the precise interactions o f the proteins with the DNA and each other remain to be 
answered. Perhaps soon all of the proteins necessary for this process will be identified 
and it will be possible to reconstitute this repair mechanism in vitro and determine the 
precise role that each protein plays in the mismatch repair pathway.
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(e) Mismatch repair and HNPCC
To date 70% of HNPCC cases have been reported to carry inherited germline mutations 
inhMSH2 and hMLHl (154, 155, 156, 157). Few germline mutations in hMSH3, 
hMSH6, hPMSl or hPMS2 have been reported, indicating that inherited mutations in 
these mismatch repair genes do not play a major role in HNPCC. It remains to be 
elucidated which, if any, mismatch repair genes are involved in the remainder of the 
HNPCC kindreds (22, 25, 160, 161, 162, 163). However, a recent study has found that 
functional deficiencies in the interaction of hMLHl and hPMS2 were associated with 
HNPCC (164). This finding suggests that inactivation of mismatch repair can occur not 
only due to lack of protein expression, but also due to lack of interaction between 
expressed proteins. In addition promoter hypermethylation of hMLHl, rather than 
mutation within the gene sequences, also results in lack of protein expression and has 
been postulated to play a role in HNPCC (165, 166, 167). Although further studies are 
necessary, this finding may provide an explanation for the remaining HNPCC cases in 
which inactivating mutations in mismatch repair genes have not yet been found.
(f) Mismatch proteins participate in processes other than mismatch repair
It is apparent that mismatch repair is a complex process and so it comes as no surprise to 
learn that some of its components have been implicated in several other cellular 
processes. For example. hMutSa has been shown to bind DNA containing a variety of 
covalent adducts, including those caused by 0 6-methylguanine, the anti-tumor drug 
cisplatin and UV light (168, 169, 170, 171). Furthermore, loss of mismatch repair activity
44
is associated with cellular resistance to these agents (172, 173). Recent studies have 
found that hMutSa binding of 0 6-methylguanine stimulated the ADP —> ATP exchange 
and activated the molecular switch function o f hM utSa (174). In addition a similar study 
found that in cells lacking MGMT (0 6-methylguanine DNA methyltransferase), 
treatment with 0 6-methylguainine inducing agents resulted in an accumulation of 
hM utSa in the nucleus in response to the damage (175).
However, evidence suggests that the involvement o f hMutSa in the binding of 
these DNA lesions does not occur as a prelude to repair but rather flags a cytotoxic event 
that may eventually signal apoptosis (179). Mismatch repair proteins have been 
associated with apoptosis induced by numerous alkylating agents in both p53 dependent 
and independent pathways (176, 177, 178, 179, 180, 181). As well, apoptosis can be 
induced in both repair deficient and proficient cell lines by the overexpression of hMSH2 
or hMLHl indicating that these proteins may be part of a pathway that influences cell 
death (182). Several models have been proposed to explain the association of mismatch 
repair proteins and the initiation of apoptosis and two are discussed below (Reviewed in 
174).
One model proposes that, since replication past an 0 6-methylguanine lesion 
would result in nucleotide mis-incorporation (183, 184), the resultant mismatched pair 
would then become a substrate for the mismatch repair system. However, since the O6- 
methylguanine lesion persists in the older DNA strand and is not repaired, this would 
lead to repeated cycles of futile repair resulting in strand breaks, cell cycle arrest and 
ultimately apoptosis Furthermore, in mismatch repair deficient cells this “futile cycle” of
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rDNA repair cannot occur, apoptosis is not initiated and results in the development of a 
damage tolerant phenotype (185, 186, 187). Another model suggests that specific types of 
DNA damage are recognized by the mismatch repair system, activate the hMutSa 
molecular switch and result in the formation of a sliding clamp in close proximity to the 
DNA lesion. However, in this scenario DNA repair is not initiated and the resulting 
accumulation o f DNA-bound sliding clamps is proposed to ultimately signal apoptosis 
(188).
Mismatch repair is also associated with transcription-coupled repair (TCR). The 
first evidence for this came from studies in E.coli where mutations in MutS and MutL 
eliminated TCR repair of UV photoproducts (189). Soon after it was found that human 
cell lines deficient in mismatch repair were also deficient in TCR of UV damage although 
NER was active in these cells (190). Follow-up studies have since found that mutation in 
either hMSH2 or hMLHl resulted in reduced TCR of damage induced by UV radiation 
whereas mutation in hMSH2 alone was associated with an inability to carry out TCR of 
damage induced by ionizing radiation (191). Furthermore, the yeast Msh2 protein has 
been found in a complex with NER proteins further linking mismatch repair to nucleotide 
excision repair (192) and a recent study has found that hMSH2, hMSH5 and hMLHl are 
components o f the BASC (BRCA1 associated genome surveillance complex) protein 
complex (193). This type o f evidence has lead researchers to suggest that, in addition to 
their roles in mismatch DNA repair, mismatch repair proteins may perform a general 
surveillance function in which they monitor the genome for many other types of damage.
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Mitotic recombination between homologous genes is one o f the mechanisms 
responsible for cells becoming homozygous for a particular recessive gene (Reviewed in 
199). Spontaneous and carcinogen-induced homologous recombination occurs most 
frequently between identical DNA sequences and has been implicated in specific genetic 
alterations required for malignant transformation, such as chromosomal rearrangements, 
translocations, deletions and gene amplifications (200). Recombination between two 
similar but non-identical sequences will form a heteroduplex intermediate containing 
mispaired DNA, which is corrected by the mismatch repair system (194). However, in 
mismatch repair defective cell lines the frequency of recombination is often dramatically 
elevated (194, 195, 196). Consequently mismatch repair activity has been found to play a 
role in removing non-homologous DNA during gene conversions and single strand 
annealing events in yeast (197, 198).
(g) Mismatch repair and the cell cycle
In proliferating mammalian cells, DNA synthesis and cell division are performed at 
specific intervals within the cell cycle (Reviewed in 201, 202). The cell cycle is a highly 
ordered process that in mammalian cells is composed of four phases: Gi —» pause or 
resting phase prior to DNA replication; S —» DNA synthesis phase; G2 —> pause after 
DNA synthesis and M —» mitosis. Along with the machinery that promotes cell cycle 
progression cells are also equipped with cell cycle checkpoints that ensure correct 
ordering of events in the cell cycle. Cell cycle checkpoints are regulatory pathways that 
control the order and timing of cell cycle transitions and ensure that critical events such
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as DNA replication are completed with accuracy (203). Cell cycle arrest at a particular 
checkpoint is also induced in response to DNA damage. For example, cells containing 
damaged DNA arrest at Gi-S and G2 -M, so as to gain time for repair and to avoid fixing 
mutations during DNA replication and cell division (204).
In addition to controlling cell-cycle arrest the proteins involved in the DNA 
damage checkpoints have also been shown to be involved in the activation o f DNA repair 
pathways (206, 207). Moreover, the reverse is also true, as it has been shown that DNA 
repair pathways are involved in the activation of DNA damage checkpoints. For example, 
G2 arrest, induced by treatment with 6-TG or MNNG, was not observed in hMLHl - 
defective cells until active mismatch repair had been restored by chromosome transfer 
(205, 208). In addition, G2 arrest induced by 0 6-methylguanine generating drugs occurred 
only in mismatch repair proficient cells and not in their mismatch repair defective 
counterparts (209).
As we know, mismatch repair in bacteria is a post-replication DNA repair 
mechanism, which functions primarily in the removal of base mismatch errors introduced 
during DNA replication. Due to the similarities between the repair systems it was 
assumed that eukaryotic mismatch repair was also a post-replication DNA repair 
mechanism. It follows, that if this were also the case in mammalian cells, then mismatch 
repair would function primarily if not exclusively in the G2 phase of the cell cycle. 
Although, there is no concrete evidence to support the theory that mismatch repair is 
active in the G2 phase of the mammalian cell cycle, the finding that the mismatch repair
Fsystem is involved in a G2 cell cycle arrest provides indirect evidence for the activity of 
this repair system in that phase of the cell cycle.
As discussed above, nucleotide mispairs occur by a variety o f processes. In 
addition, it has been shown that mismatch repair proteins recognize many types of DNA 
damage that occur throughout the cell cycle. We therefore speculated that the mismatch 
repair system functions in phases of the cell cycle other than G2 . Previous investigations 
have found that levels of the mismatch repair proteins hMSH2, hMLHl and hPMS2 do 
not change appreciably throughout the cell cycle (210, 211) and that expression of 
mismatch repair proteins occurs in tissues that no longer replicate (212). However, the 
presence of these proteins is not necessarily an indicator of activity and may be due to 
their putative roles in damage recognition or damage surveillance. One of the goals of 
this research has been to determine if the mismatch repair system is active in the repair of 
several base: base mismatches at the codon 12 H-ras hotspot of mutation during the Gi 
phase of the mammalian cell cycle.
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FPART II: Effects o f  p,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot
The Inupiat residents of Alaska along the Arctic Ocean coast are concerned that 
traditional food sources containing environmental pollutants, such as pesticide residues 
and heavy metals, may contribute to their unique childhood and adult disease profile 
(213).
In 1996 the community health department of the Alaska Area Native Health 
Service began a preliminary study of maternal blood plasma and newborn umbilical cord 
blood from residents of the northern coastal town o f Barrow. Blood samples thus far 
collected have been analyzed for the presence of various environmental contaminants. In 
addition to other chemicals, measurable levels of p,p’-DDE (1,1 dichloro-2,2-bis(p- 
chlorophenyl)ethylene), (hereafter DDE) were found in 100% of the samples studied. In 
maternal plasma the concentration of DDE ranged from 0.353-3 .505 fj.g/1 (20 samples) 
with an average concentration of 1.263f^ g/1. Newborn umbilical cord blood 
concentrations of DDE ranged from 0.118-0.840 fj.g/1 (24 samples) with an average 
concentration of 0.331 p.g/1 (214).
DDE is the major metabolic breakdown product of the pesticide DDT (1,1,1 
trichloro-2,2-bis-(p-chlorophenyl)ethane). The use o f DDT was banned in the United 
States and in many other countries in the early 1970’s when environmentalists 
determined that there were links between DDT and various ecological disturbances, 
including the decline of selected bird populations and numerous instances of fish kills
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(215). Insecticidal use o f DDT still persists today in many countries including southern 
Asia, Central and South America and Africa (216).
Due to the complex ring structure of DDT, slow biotransformation occurs in 
mammals resulting in the accumulation of DDT and its metabolites in body tissues (217) 
Analysis of human tissues exposed directly to DDT yields a ratio o f approximately 5 
PPM DDT to 15 PPM DDT metabolites (primarily DDE) (215). As well, serum from rats 
exposed to dietary DDT contains a mixture composed of a greater amount of the parent 
compound than its metabolites (218). However, no measurable amounts of DDT were 
found in any of the blood samples tested indicating that the Alaskan Inupiat population is 
not exposed directly to the parent compound. Rather, the presence o f only DDE indicates 
that exposure occurs primarily through the biomagnification o f this persistent metabolite 
through the worldwide food chain.
DDE is extremely lipophilic and accumulates in adipose tissue (219, 220) As well, 
it has been reported that species with long life spans can accumulate high tissue levels of 
the compound (221). The Alaskan Inupiat, maintaining a subsistence lifestyle, 
preferentially consumes the adipose tissue of animals at the higher trophic levels of the 
food chain, (e.g. whales, seals and walruses). A diet consisting of foods from these 
sources is thought to be the primary exposure route of this human population to DDE. 
Although some environmental monitoring for DDE and other chemicals is currently 
ongoing, there is, as yet, no reliable estimate of the amount o f DDE that the Alaska 
Inupiat, depending on lifestyle and dietary habits, may be exposed to.
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The EPA has listed DDE as a probable human carcinogen (222). The chemical 
has been found to induce liver tumors in mice (223), to cause DNA strand breaks in 
Chinese hamster cells (224) and to inhibit platelet aggregation (225). DDE exposure in 
utero results in the demasculinization of male rats, which is manifested by reduced 
angogenital distance and retained thoracic nipples (226). Both in vivo and in vitro studies 
have identified DDE as an androgen receptor antagonist and an inhibitor of androgen- 
induced transcriptional activity (227, 228). Furthermore, it has been demonstrated that 
DDE is an inducer of the phenobarbital (PB) -type cytochrome P-450 (CYP) mixed- 
function monoxygenases (229). It has been proposed that the demasculinizing effects of 
DDE may be due to both the chemical’s anti-androgenic effects and induced expression 
of the CYP-enzymes (230). However, the DDE concentrations used in all of the 
aforementioned studies are several orders of magnitude greater than the concentrations 
measured in the Alaskan blood samples.
Current evidence indicates that fetuses and infants are more susceptible than 
adults to a variety of environmental toxicants. A recent report demonstrated that several 
of the CYP enzymes, such as those involved in testosterone metabolism, were induced in 
rats exposed to low levels of DDE, although the sexual and developmental defects 
observed at the higher doses were absent (230). These inappropriate enzyme inductions 
may have serious consequences for the developing embryo at a time when it is 
physiologically immature and most sensitive to hormone fluctuations (23 1). Therefore, in 
this study we investigated the effects of DDE exposure on two different cell types. NIH 
3T3 is an immortal aneuploid murine embryonic fibroblast cell line. WS1 cells are non­
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transformed human embryonic fibroblasts with a normal chromosome number. Inclusion 
of these two distinct cell types enabled us to identify the common cellular effects of DDE 
on immature mammalian cells as well as those effects unique to the WS1 human fetal 
cells.
The aim of these studies was to determine whether concentrations o f DDE, 
relevant to the Alaskan environment, had any measurable toxic effect on immature 
mammalian cells in culture including site-specific DNA mismatch repair as discussed 
previously Initial experiments were performed to determine if exposure to DDE had any 
effect on the overall cell quantity per exposed plate of either cell type. Based on these 
initial positive results, subsequent short-term and long-term exposure assays were 
performed to determine possible mechanisms for these observed fluctuations in cell 
number. Decreases in cell number could be due to cell death, either by necrosis or 
apoptosis, or cell cycle arrest As discussed in part I, a delay or arrest in the progression 
of a proliferating cell through the cell cycle can occur in response to DNA damage. DNA 
damage can trigger cell cycle arrest at virtually any point in the cell cycle so as to provide 
additional time both for the transcription of DNA repair genes and the repair o f DNA 
damage (232, 233).
In an attempt to elucidate the genotoxic potential of DDE, we included assays 
which examined the direct DNA damaging potential of DDE as well as the chemical’s 
effect on the ability of both cell types to repair specific types of DNA damage. The 
Comet assay was used to examine the genotoxicity of DDE and a modification of an in 
vivo DNA repair assay was used to investigate the effect of DDE on DNA repair
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Briefly, two base:base mismatches were constructed at the oncogenic codon 12 H-ras 
hotspot using a method similar to that employed in previous studies (see materials and 
methods). The DNA was then introduced into both embryonic cell types in the presence 
of DDE and the mismatch repair rates at this oncogenic hotspot were subsequently 
determined. Although preliminary, the results o f this study show that relatively small 
concentrations o f persistant organic pollutants, such as DDE, exert effects on several 
different processes in immature cells in culture.
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n. MATERIALS AND METHODS
A. Reagents 2,2-bis(4-chlorophenvl)-l,l-dichloroethylene (DDE) was purchased from 
Aldrich-Sigma chemical company Dulbecco’s modified Eagle medium (DMEM), 
minimum essential medium (MEM), OptiMem, Lipofectamine transfection reagent and 
Trypsin-EDTA were purchased from Gibco BRL Life Technologies Inc. Clonfectin 
liposome reagent was purchased from Clontech Inc. Fetal bovine serum (FBS) and 
bovine calf serum (CS) were purchased from Hyclone Laboratories. Hygromycin was 
purchased from Calbiochem-Novabiochem Corporation. Streptavidin-horseradish 
peroxidase, anti-mouse immunoglobulin antibody, Thermosequenase sequencing and 
ECL Western blotting detection kits were purchased from Amersham Pharmacia Biotech. 
SeaKem GTG and Nusieve 3:1 agarose were purchased from FMC Bioproducts.
Qiaquick Gel Extraction and Qiaquick PCR purification kits were purchased from Qiagen 
Inc. The Prime-a-gene nick translation kit was purchased from Promega. The Quantum 
Prep plasmid miniprep kit was purchased from Biorad Laboratories Inc. Sephadex G50, 
G100, Proteinase K, phenol: chloroform: isoamyl alcohol (25: 24: 1), PMSF (phenyl 
methyl sulfonyl fluride), DTT (dithiothreitol), DMSO, 10X Denhardt’s reagent, Sigma- 
Fluor scintillation cocktail, denatured salmon sperm, carbenicillin, kanamycin and all 
other chemicals and reagents were purchased from Sigma Chemical company unless 
otherwise stated.
B. Cell lines and bacteria. NIH 3T3 and W S1 cell lines were purchased from American 
Type Culture Collection (ATCC). NIH 3T3 cells were grown in DMEM/10% CS. WS1
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cells were grown in M EM /10% FBS. Both cell cultures were maintained at 37°C in 5% 
C 02. Competent DH5a E.coli bacteria were purchased from Life Technologies Inc 
NR9374 (Mut L- and Mut Y-) E.coli bacteria were a kind gift from Dr. Roel M.
Schaaper, National Institute o f Environmental Health Sciences.
C. DNA: Plasmids pbc-Nl and pT24-C3 were purchased from American Type Culture 
Collection (ATCC). Plasmid p220.2 was a kind gift from Dr. William Sugden, University 
of Wisconsin. M13mpl8 and M13mpl9 were purchased from Sigma Chemical 
Company. All synthetic oligonucleotides were purchased from Operon Technologies Inc. 
Radioactively labeled nucleotides were purchased from NEN Life Science Products, Inc.
D. Enzymes. A flill, Pvul, Hindlll, Dpnl, Dpnll, EcorV  and BamHl were purchased from 
New England Biolabs. Bst9Sl and Turbo Nael were purchased from Promega 
Corporation. Xhol, Kpnl and T4 ligase were purchased from Boehringer Mannheim 
Corporation. Shrimp alkaline phospatase (SAP), Exonucleasel and T4 polynucleotide 
kinase were purchased from USB Corporation. Amplitherm PCR enzyme was purchased 
from Epicenter technologies.
E. Plasmid and M l 3 constructs
Previously this laboratory had taken the following steps to produce the plasmids and M13 
bacteriophage constructs used in the preparation of mismatched plasmids (234). First, a 
shuttle vector containing human H-ras genomic DNA was constructed by inserting the 
wild-type (wt) human H-/ov genomic sequence (BamHl 6.4 kb segment from pbc-Nl)
F
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into the BamHl site in the polylinker region of the Epstein-Barr Virus (EBV) shuttle 
vector p220.2 Removal of the original H indlll site in the polvlinker region of p220.pbc 
was then accomplished by DNA polymerase I (Klenow fragment) 5’ —> 3’ exonucleolytic 
digestion and subsequent blunt-end ligation by standard procedure to produce p220.pbc- 
H/B plasmid.
A 2 kb BamHl -  Kpnl segment of p220.pbc-H/B containing exon 1 was ligated 
into the polylinker region of bacteriophage M13mp 19 and subjected to oligo-directed 
mutagenesis to create two new restriction enzyme recognition sites, Hindlll and Z?.v/98I,
30 base-pairs apart flanking H-ras codon 12 in exon 1. Three separate rounds of 
oligonucleotide-directed mutagenesis were performed with the M13-ra.y plasmid to 
change a total of four bases: codon 6 : G —» T (no amino acid change but creates a unique 
Hindlll site) and codon 15: GGC —» CTT (Gly —» Leu, both neutral non-polar amino 
acids, to create a unique Bst9Sl site). Restriction digestion and dideoxy sequencing were 
used to select M n + ras  clones that contained only the above-indicated base changes. The 
BamHl -  Kpnl segment, containing the new sites, was excised from the double-stranded 
M13+ra.v DNA and inserted into p220.pbc-H/B in place o f the original 2 kb H-ra.v 
segment thus producing the modified plasmid renamed p220.pbc+H/B.
Next, the 2 kb BamHl - Kpnl segment o f the H-ra.v gene, containing codon 12, was 
isolated from the p220.pbc+H/B plasmid and ligated into the polylinker region of pUC 
19, M13mp 18 and M13mp 19 to produce pra.vBK2.0, M13ra.v 18.9 (+ strand contains 
non-coding sequence from H-ra.v) and M13ra.v 19.1 (+ strand contains coding sequence 
from H-ra.v) respectively.
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FPART I: Mismatch repair at an oncogenic hotspot in Gi synchronized mammalian 
cells
Section I: Method o f  Gi synchronization, fluorescent activated cell sorting analysis, 
plasmid replication kinetics and mismatch repair protein expression in Gi nuclear 
extracts
A. Gi synchronization andfluorescent activated cell sorting analysis 
Gi synchrony was achieved using the serum starvation method as described by 
Rabinovitch et al 1990 (235). NIH 3T3 cells were seeded in duplicate at 4.9 x 105 cells 
per 10 cm dish in media containing either 0.25% CS or 10% CS (controls) and incubated 
for 3 days at 37°C in 5% CO2 . At designated time-points (see Table 3) on days 2 and 3 
duplicate samples were harvested as follows. At each time-point media was removed and 
each plate rinsed with 5 mis of IX PBS. 3 mis of 0.025% Trypsin-EDTA was then added 
and plates were returned to the 37°C incubator for 3 minutes. The Trypsin- EDTA/cell 
solution was then removed to a pre-chilled disposable conical vial containing 3 mis of 
DMEM/10% CS/10% DMSO, and pelleted by centrifugation at 200 x g at 4°C for 5 
minutes. Finally, all but 20-50|j.l of the liquid was aspirated off and the pellets were 
frozen at -70°C.
On day 4 at 0 hrs the media on all remaining plates was replaced with fresh media 
(DMEM + serum) containing 10% CS and the plates were returned to the incubator. At 2 
hr intervals between 0 and 24 hr, after the addition o f fresh media, duplicate plates were 
harvested, (as described above). The completed experiment was then shipped frozen on
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dry ice to the laboratory of Dr. Peter Rabinovitch at the University o f Washington 
(Seattle, WA) where flow cytometric analysis was performed. The number of cells in the 
Gi, S, G2/M phases of the cell cycle were quantified using the 4,6-diamidino-2- 
phenylindole reagent for DNA quantification (236).
B. Plasmid replication kinetics
Replication of the p220.pbc plasmid within synchronized NIH 3T3 cells was studied to 
determine if the plasmid continued to replicate synchronously with the cell cycle 
following Gi arrest.
(i) Transfection o f  Gi synchronized cells
NIH 3T3 cells were plated at 1.1 X 106 cells in a 15 cm dish in media containing either 
0.25% or 10% CS (controls) and incubated for 3 days at 37°C in 5% CO2 . On day 4, 1 
hour prior to the start of transfection, all plates were re-fed with fresh DMEM containing 
10% CS.
A 3 (ig aliquot o f p220.pbc-H/B and 300 |ig of Lipofectamine were added to 200 
(il of OptiMem and incubated for 30 minutes at room temperature. Each plate was rinsed 
with 10 mis of IX PBS and then 5 mis of OptiMEM was added followed by the plasmid 
transfection mixture. The plates were then placed at 37°C with gentle rotation for 30 
minutes followed by a further 5 'A hour incubation without agitation at 37°C in 5% CO2 .
At the end of this period the transfection mixture was removed and replaced with media 
containing 10% CS and the plates were returned to the incubator At various time-points
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(see Figure 8) duplicate control and synchronized plates were harvested as follows. Each 
plate was rinsed with 10 mis 1 X PBS and incubated for 5 minutes at 37°C with 5 mis of 
0.025% Trypsin-EDTA. The contents o f each plate were then removed to a conical vial, 
containing 5 mis of DMEM/10% CS, centrifuged for 5 minutes at 200 x g and frozen at - 
20°C.
(ii) Plasmid recovery and digestion
Plasmid DNA from each of the frozen cell pellets was recovered using the Quantum Prep 
Plasmid Miniprep kit as described by the manufacturer (Biorad Laboratories Inc.). Each 
sample was then digested with 10 units of Dpnll. Digestion o f DNA by D pnll enzyme is 
blocked by prokaryotic adenine methylation and therefore only that DNA which has 
replicated 2 or more times in mammalian cells will be digested. As a control, included 
with each set of samples were control reactions containing p220.pbc -H/B DNA treated 
with either Dpnl or Dpnll. Dpnl digests DNA at the same restriction sites as Dpnll but 
only when that DNA has been methylated at adenine residues. The completed digest 
reactions were then electrophoresed on a 1% Seachem GTG agarose gel.
(iii) DNA transfer and immobilization (Southern Blot)
The agarose gel from step (ii) was then immersed in, 0.25 N HCL for 30 minutes, then 
denaturing buffer (3M NaCl, 0.4M NaOH) for 30 minutes and finally washed in alkaline 
transfer buffer (3M NaCl, 8mM NaOH) for 15 minutes. The DNA was then transferred 
under alkaline conditions to an S+S Nvtran positively charged nylon membrane using the
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alkaline capillary transfer method as described by the manufacturer (Schleicher and 
Schuell, Inc.) Following transfer, the membrane was neutralized in 0.2 M sodium 
phosphate pH 6.8 for 3 minutes and the DNA immobilized on the membrane by UV 
cross-linking. Briefly, the damp membrane was exposed in an UV Stratalinker 
(Stratagene) to UV at 254 nm for 5 minutes at a distance of approximately 15 cm from 
the light source. The total UV exposure of the membrane was 120 mj/cm2.
(iv) Radioactive probe preparation
The p220.pbc-H/B plasmid, at a final concentration of 100 ng/jj.1, was digested with each 
of the enzymes EcoRW and BamHl (2 units per p.g DNA). The digestion products were 
then separated by electrophoresis on a 1% SeaKem GTG agarose gel. The 613 bp 
EcoRV/BamH  1 fragment was excised from the gel and recovered using the Qiaquick Gel 
Extraction Kit as described by the manufacturer and quantified.
The 613-bp EcoRV/BamHl fragment (hereafter referred to as the DNA probe) 
was then radioactively labeled with [a]-32p CTP (6000 Ci/mMol, NEN Life science 
products, Inc.) using the Prime-a-Gene Nick Translation Kit as described by the 
manufacturer (Promega Corporation Inc.). The reaction was then passed through a G100 
sephadex column in order to remove all unincorporated radioactive nucleotide. The 
specific activity of each labeled probe preparation was assessed by liquid scintillation 
counting in 5 mis of Sigma-Fluor liquid scintillation cocktail. Only those radioactively 
labeled probes whose activity was 109 cpm/fig of DNA or greater were used in 
subsequent hybridization steps.
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(v) Hybridization
The UV crosslinked membrane from (ii) was incubated at 42°C for 2 hours with agitation 
in pre-hybridization buffer (50% formamide, 6X SSPE, 5X Denhardt’s reagent, 1% SDS, 
100 fig/ml denatured salmon sperm DNA). The radioactively labeled DNA probe from 
step (iv) was denatured at 95°C for 5 minutes and placed on ice. The membrane was 
immersed in hybridization buffer (50% formamide, 6X SSPE, 5X Denhardt’s reagent, 
0.5% SDS, 100 fig/ml denatured salmon sperm DNA), at a volume of 1 ml of 
hybridization buffer per lxlO5 cpms of radioactive probe, then the denatured probe was 
added and the membrane was incubated at 42°C overnight in a shaking water-bath. The 
membrane was then washed as follows: 3 times in 7X SSPE + 0.5% SDS for 15 minutes; 
twice in IX SSPE + 1%SDS for 15 minutes at 37°C: and finally for 1 hour at 42°C in 
0. IX SSPE + 1% SDS. The moist membrane was then wrapped in saran wrap and 
exposed to Biomax X-ray film (Eastman Kodak Corporation) at -70°C with an 
intensifying screen.
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This assay was performed to determine if the mismatch repair protein MSH2 could be 
detected in nuclear extracts prepared from Gi synchronized NIH 3T3 cells.
(i) G i nuclear extract preparation
NIH 3T3 cells were plated at 1 x 106 cells per 15 cm plate in DMEM/10% CS. Twenty- 
four hours later the media was replaced with DMEM / 0.25% CS and the cells incubated 
for a further 3 days to achieve Gi synchrony (see Table 3).
Nuclear and cytoplasmic extracts were prepared by the method of Dignam et al 
with some changes as described below (237). On day 4 the cells were harvested by 
trypsinization and centrifuged at 450 x g at 4°C for 3 minutes. The pelleted cells were re­
suspended in isotonic buffer (20 mM Hepes pH 7.9, 20% glycerol, 0.1 M KCL, 0.2 mM 
EDTA, 0.5 mM PMSF [phenylmethylsulfonyl fluoride], 0.5 mM DTT [dithiothreitol], 
and centrifuged at 450 x g at 4°C for 3 minutes. The cell pellet was then washed with 5 
mis of hypotonic buffer, (20mM Hepes pH 7.9, 5mM KCL, 0.5 mM MgCU, 0 2 M 
sucrose), re-suspended at 2 X 107 cells/ml in the same buffer and placed on ice for 10 
minutes. The cells were then lysed with 10 strokes o f a Dounce homogenizer, observed 
microscopically for plasma membrane lysis and centrifuged at 300 x g at 4°C for 3 
minutes to pellet the nuclei. The supernatant (cytoplasmic extract) was subsequently 
removed and stored frozen at -70°C.
The nuclei pellet was re-suspended at 2 X 108 cells/ml in Buffer A (hypotonic 
buffer plus 0 5 mM DTT and 0 1% PMSF) The nuclei solution was mixed by rotation
C. Mismatch repair protein expression in Gi nuclear extracts
with the addition of 0.03875 volumes of 4M NaCl for 1 hour at 4°C followed by 
centrifugation for 20 minutes at 15,000 x g at 4°C The supernatant (nuclear proteins) 
was removed and mixed by rotation for 30 minutes at 4°C with the addition o f 0.42 g/ml 
of (NH4)2S 04 and then centrifuged at 16,000 x g at 4°C for 30 minutes. The pellet was 
then re-suspended at 1.8 x 109 cells/ml in resuspension buffer (20 mM Hepes pH 7 9,
20% glycerol, 0.1 M KCL, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT) and dialyzed 
against 50 volumes of the same buffer for 90 minutes at 4°C and subsequently stored at - 
70°C. The nuclear and cytoplasmic protein extracts were quantified by the Bradford 
assay (238).
(ii) Western blotting
Gi nuclear and cytoplasmic extracts (15 -  20 (ig protein per lane) were mixed with an 
equal volume of 2X SDS sample buffer (1% Tris-HCL/SDS pH 6.8, 6% SDS, 20% 
glycerol, 2% 2-mercaptoethanol, 10 |i.g/ml bromophenol blue) The samples were heated 
for 5 minutes at 100°C with the caps open, placed on ice and loaded onto a 7.5% 
discontinuous SDS polyacrylamide gel (stacking gel 30% acrylamide/ 0.8% 
bisacrylamide, 4% Tris-HCL/SDS pH 6.8: separating gel 30% acrylamide/0.8% 
bisacrylamide, 4% Tris/HCL/SDS pH 8.8) and electophoresed at 10 mA for 2 hours.
The resulting gel was then transferred overnight at 10 mA onto a pre-wetted 
nitrocellulose membrane (Schleicher and Schuell, Inc.) using a Trans-Blot apparatus 
(Bio-rad Laboratories, Inc.) in a transfer buffer consisting of 2.5 mM Tris and 19.2 mM 
glycine
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Next, the membrane was placed in blocking buffer (5% non-fat milk in Tris- 
buffered saline pH 7.6, 0.1% Tween 20) for 1 hour with agitation. The membrane was 
then washed by rinsing briefly twice in TBS-T (Tris buffered saline pH 7.8, 0.05%
Tween 20), placing the membrane in fresh TBS-T with agitation for 15 minutes and then 
placing it again in fresh TBS-T twice more for 5 minutes with agitation. The membrane 
was next incubated with MSH2 primary antibody (Santa Cruz Biotechnology) at a 1:200 
dilution with agitation for 1 hour. Excess primary antibody was washed from the 
membrane by rinsing twice briefly in TBS-T, placing the membrane in fresh TBS-T with 
agitation for 15 minutes and then placing it again in fresh TBS-T twice for 5 minutes with 
agitation. The membrane was then incubated in TBS-T with a horseradish peroxidase 
(HRP)- conjugated anti-mouse immunoglobulin antibody at a dilution of 1:1000. Excess 
secondary antibody was washed from the membrane again by rinsing briefly twice in 
TBS-T, placing the membrane in fresh TBS-T with agitation for 15 minutes and then 
placing it in fresh TBS-T twice more for 5 minutes with agitation. Bound antibodies were 
detected by ECL detection of the HRP enzyme as described by the manufacturer 
(Amersham Pharmacia Biotech)
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rSection II: Mismatch repair in the G / phase o f  the mammalian cell cycle
A. Mismatch construction at codon 12 o f  H-ras
(i) Fragment preparation
Mismatches at the middle base pair position of codon 12 of W-ras were prepared by the 
following method. The first step was to digest 100 jig of the prasBK2.0 plasmid with 
b o th ^ /m i and Pvul enzymes. The reaction mix contained 1 unit enzyme/(ig plasmid 
DNA with a final concentration of 0.25 ^g DNA/fil and released a 2.5 kb fragment 
containing the inserted H-ras segment. The products o f this reaction were then digested 
with Bst9Sl in a final DNA concentration o f 50 ng/|il using 10 units of enzyme/(j.g DNA. 
The products from the Bst9Sl digest were then digested with Hindlll using 10 units 
enzyme/|ig DNA. The four restriction enzyme digestions produce fragments of size 17 
kb, 392 bp, 305 bp and selectively excise the 30 bp segment containing codon 12 of H- 
ras from the ras containing DNA (Figure 5, step 1).
(ii) Oligonucleotides
Oligonucleoides complementary to the 30 bp region comprising codon 6 —» codon 15 but 
containing an incorrect nucleotide at the middle nucleotide position of codon 12 were 
obtained from Operon Technologies Inc. Coding strand oligonucleotides had the 
sequence 5’ GGT GGG CGC CGG CGG TGT GGG CAA GAG TGC GC -  3’, with the 
bolded G replaced with either a T to produce T:C mismatches or an A to produce A:C 
mismatches at H-ras codon 12 middle base position. Non-coding strand oligonucleotides 
had the sequence 5’ GCG CAC TCT TGC CCA CAC CGC CGG CGC CCA CC 3’.
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with the bolded C replaced either with a T to produce a G:T mismatch or with an A to 
produce a G:A mismatch at the middle base position o f codon 12, W-ras.
Each of the four oligonucleotides were 5’ phosphorylated using T4 polynucleotide 
kinase at a final DNA concentration of 0.125 |j.g/}j.l using 16 units enzyme/ng as 
described by the manufacturer. The reactions were incubated at 37°C for 60 minutes and 
then centrifuged through a dt^O equilibrated Sephadex G-50 spin column at 300 x g for 3 
minutes. The phosphorylated oligonucleotides were then stored frozen at -70°C in ddf^O 
at a final concentration of 500 ng/pil.
(iii) Melt and reanneal fo r  site- and strand- specific mismatch construction 
Generation of heteroduplex DNA was made according to the choice of mismatched 30 bp 
oligonucleotide and single stranded M l 3ras complementary DNA. Use of single-stranded 
M13ray 18.9 (non-coding strand) and the appropriate mismatch-containing coding strand 
oligonucleotide produced T:C and A:C mismatches. Use o f single-stranded M13rav 19.1 
(coding strand) and the appropriate mismatch-containing non-coding strand 
oligonucleotide resulted in G:T or G:A mismatches.
Double-stranded mismatches were created by annealing the phosphorylated 
oligonucleotide with the complementary single stranded M13ra.s DNA and the DNA 
fragments produced in the Afllll, P m  I, Bst9%[ and Hindlll digests of pra.vBK2.0 at a 
50:1:1 molar ratio of oligonucleotide: M13ra.v: fragments. The fragments were heated for 
10 minutes at 100°C and then cooled to 95°C over 2 minutes. During the cool down 
period the M O ras, 10X annealing buffer (400 nM Tris pH 7 5, 200 nM MgChand 500
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nM NaCl) and mismatch oligonucleotides were added to a final concentration of 50 ng/(j.l 
DNA and IX annealing buffer The reaction was then allowed to cool to 22°C over 150 
minutes (Figure 5, step 2).
(iv) Isolation o f  the site- and strand-specific mismatch containing 1.8 kb fragment 
The melt and re-anneal reaction mix containing the partially double-stranded M 13ra.v 
molecule was next cleaned using the Qiaquick PCR purification kit as described by the 
manufacturer (Qiagen Inc). The elutant was next digested with 20 units each of the 
enzymes Xhol and Kpnl per (j.g of DNA at a final concentration o f 100 ng DNA/|j.l. The 
reaction contents were then separated by electrophoresis on a 0.8% SeaKem GTG 
agarose gel. The 1.8 kb mismatch containing fragment was then excised, purified using 
the Qiaquick Gel Extraction Kit as described by the manufacturer (Qiagen, Inc.) and 
quantified (Figure 5, step 3).
(vj Assembly o f  the completed mismatched plasmid
Vector preparation. The p220.pbc-H/B plasmid was digested with 20 units each of Xhol 
and Kpnl per |ig DNA at a final concentration of 100 ng DNA/|il. The reaction products 
were subsequently separated by electrophoresis overnight at low voltage on a 0.7% 
SeaKem GTG agarose gel. The 13.5 kb band was excised, purified as above and 
quantified. This vector contained the remaining W-ras genomic sequence (minus the 1.8 
kb fragment), Epstein-Barr Virus (EBV) origin of replication, eukaryotic hvgromycin 
resistance, bacterial carbenicillin resistance and bacterial replication sequences (246)
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Annealing and ligation. To ensure that the mismatch-containing oligonucleotide 
was indeed present, a greater excess o f mismatch-containing oligonucleotide was again 
annealed to the fragment. Phosphorylated oligonucleotide and the 1.8 kb fragment were 
mixed together at a 200:1 molar ratio o f oligonucleotide. 1.8 kb fragment at a DNA 
concentration of 30 ng/jj.1 in a buffer consisting of 50 mM Tris-HCL pH 7 6, 10 nM 
dithiothreitol and 500 (ig/ml bovine serum albumin. The mixture was placed in a 2-liter 
beaker containing 85-90°C water and allowed to cool slowly to room temperature. The
1.8 kb fragment was then ligated to the 13.5 kb Xhol / Kpnl vector at a 2:1 molar ratio of 
fragment to vector using 0.5 units T4 DNA Ligase per (j.g DNA as described by the 
manufacturer (Boehringer Mannheim). This final ligation step produced a p220.pbc+H/B 
plasmid containing a site- and strand-specific mismatch at H-ras codon 12, middle base 
pair position (Figure 5, step 4). In addition, this heteroduplex was easily distinguished 
from any undigested vector contamination (p220.pbc-H/B) by the presence of the Hindlll 
and Bst 981 sites at codons 6 and 15 respectively.
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rB. Transfection o f  Gi synchronized NIH 3T3 cells and transformation D H 5a E.coli with 
mismatched plasmid
(i) Bacterial transformation: Competent E.coli DH5a cells were transformed with 50 ng 
of mismatch containing plasmid as described by the manufacturer and were grown 
overnight at 37°C on LB agar containing 100 ng/ml carbenicillin.
(ii) Transfection o f Gi synchronized NIH 3T3 cells
For in vivo repair of mismatches in Gi synchronized cells, NIH 3T3 cells were seeded at 
4.9 x 105 cells per 10 cm plate in DMEM containing 0.25% CS and incubated for 3 days 
at 37°C in 5% CO2 . On day 4, 1 hour prior to the start o f transfection, the media on each 
plate was replaced with fresh DMEM and 10% CS.
For each plate, 175 ng of mismatched plasmid and 17.5 M-g o f Clonfectin liposome 
reagent (prepared as described by the manufacturer, Clontech Inc.) were added to 200 jj.1 
of OptiMEM and incubated at room temperature for 30 minutes. Each plate was rinsed 
with 5 mis 1 X PBS, followed by the addition of 3 mis of OptiMEM and the plasmid 
mixture. The plates were then placed at 37°C with gentle rotation for 30 minutes 
followed by 3 Vz hours in 37°C, 5% CO2 without agitation. At the end of this time the 
OptiMEM was removed and replaced with DMEM + 10% CS and the plates were 
returned to the incubator. NIH 3T3 hygromycin resistant cells were subsequently selected 
for by the addition of 125 units of hygromycin per ml of media, starting 48 hours after 
transfection. At the end of 3 weeks, hygromycin resistant colonies on each plate were
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methanol fixed (97%) and stained with 1% crystal violet in 20% ethanol. Included with 
each transfection were positive (p220.pbc -H/B) and negative (no DNA) control plates.
C. Mismatch repair analysis
(i) DNA extraction
Bacteria'. Plasmid DNA from carbenicillin resistant D H 5a colonies was isolated by the 
following method. Individual bacterial colonies were removed from the plates with a 
sterile toothpick and placed in 0.5-ml microcentrifuge tubes. To each sample tube a 100 
|j.l aliquot of lysis buffer (10 mM Tris-HCL pH 8.3, 50 mM KCL. 0.1 mg/ml gelatin,
0.45% NP-40, 0.45% Tween 20, 2.5 mM MgCh), containing 12 ug of Proteinase K 
(Sigma Chemical Company) was added (239). The tubes were incubated for 1 hour at 
55°C followed by 10 minutes at 95°C. The samples were then extracted with 2 volumes 
of phenol: chloroform: isoamyl alcohol, and precipitated overnight at -20°C in 1/10 
volume of 3 M sodium acetate and two volumes of 100% ethanol. The DNA was pelleted 
by centrifugation for 30 minutes at 12,000 x g, dried by vacuum centrifugation with heat 
for 20 minutes and finally resuspended in 10 |j.l of sterile dd^O .
NIH 3T3 cells: To analyze repair of mismatches in vivo in Gi synchronized NIH 3T3 
cells. DNA was isolated from hygromycin resistant colonies by the following method. 
Cloning cylinders (Bellco Glass, Inc.) were placed over each previously fixed and stained 
colony and were adhered to the culture dish with sterile silicone vacuum grease. A 100 jj.1 
aliquot of lysis buffer (described above) containing 12 jig Proteinase K was added to the
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Fcloning ring and incubated for 10 minutes at room temperature. The solution in each 
cloning ring was repeatedly aspirated to dislodge any remaining cells from the culture 
plate and subsequently transferred to a 0.5-ml centrifuge tube and incubated for 1 hour at 
55°C followed bylO minutes at 95°C. The samples were then extracted and precipitated 
exactly as described above for E.coli. The DNA lysates were then re-suspended in 10 jj.1 
of sterile ddH20  and used in the PCR amplification reaction described below
(ii) PCR amplification
A 5-jj.I aliquot of each DNA lysate from each colony {E.coli and NIH 3T3) was PCR 
amplified with 2.5 units of Amplitherm enzyme (Epicenter Technologies) in the supplied 
buffer plus 3 .5 mM MgCb, 200 (0.M of each dNTP and 100 ng o f each primer (described 
below) in a final volume of 100 (il, with the amplitherm enzyme separated from the other 
reactants by a wax layer (Chill-Out 14, MJ Research, Inc.). The reactions were heated to 
95°C for 3 minutes followed by 35 cycles of 40 seconds at 96°C, 40 seconds at 61°C and 
1 minute at 72°C. The samples were then incubated for an additional 7 minutes at 72°C to 
allow completion of extension reactions and finally cooled to 4°C.
The primers used for the PCR reaction were: 5’ H-/m —> 5’-TGA GGA GCG 
ATG ACG GAA TAT-3’ and 3’ H-ras ->5’ CAG GCT CAC CTC TAT AGT GGG 
GTC-3’ (Operon Technologies Inc.). Amplification using these primers produces a DNA 
product of 129 bp containing exon 1 of human H-ras plus several base pairs of the 
intronic region surrounding exon 1, thus precluding amplification of mouse genomic H- 
ras. Several negative controls (no DNA added to PCR reaction) and positive controls
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(0.01 ng p220.pbc-H/B added to PCR reaction) were included with each set of PCR 
amplification reactions. Amplification was determined by electrophoresis on a 2% 
SeaKem GTG agarose gel (Figure 6, A).
(iii) Contamination check o f  amplified H-ras segment
Each PCR amplified sample was tested to confirm that it did not result from transfection 
of undigested vector (p220.pbc -H/B). 20 (j.1 of amplified product was purified with 
Qiagen’s PCR Purification kit, as described by the manufacturer, and digested with 100 
units o f H indlll enzyme. The samples were examined by electophoresis on a 4% NuSieve 
3:1 agarose gel. Only those samples which had been PCR amplified from the +H/B 
mismatched plasmid are cut by this enzyme to produce two fragments o f which only the 
larger 107 bp fragment is clearly visible on the agarose gel (Figure 6, B).
(iv) Mismatch repair analysis
A 20 fj.1 aliquot of each +H/B amplified PCR product was digested with 4 units of Turbo 
Nael restriction enzyme in the supplied buffer for 4 hours. The products of this reaction 
were electophoresed on a 4% NuSieve 3:1 gel and analyzed. Only PCR amplified DNA 
containing the wild-type sequence at codon 12 of H-ras is cleaved by this enzyme giving 
rise to two distinctly smaller DNA fragments o f size 88 and 41 bp (Figure 6, C). If the 
PCR amplified DNA in a particular sample indicated either incomplete or complete lack 
of cutting an aliquot of the sample was sequenced in order to determine the exact 
sequence at codon 12.
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Sample
Figure 6 : Mismatch repair analysis
Examples of (A) PCR amplification, (B) HindlJJ verification, and (C) Nael 
digest mismatch repair rate determination
Lane 0 in A + B + C contains 25 bp ladder with the —> indicating the 125 bp band.
(A) PCR amplification; Lanes 1. 3-6 contain the amplified 129 bp fragment of H-ras 
Lane 2 represents a negative control sample into which no DNA has been added.
(B) Hindlll digest of PCR product to test for -H/B plasmid contamination. Lanes 1.3.6,7 
contain PCR product which has been cleaved by Hindlll to produce a 107 bp band, thus 
indicating the presence of a +H/B mismatched plasmid. The sample in Lane 4 remains 
undigested by Hindlll indicating that this sample resulted from -H/B plasmid 
contamination (see text for explanation)
Figure 6 continued
(C) NaeI digests of +H/B PCR product. Lanes 1.3.7. show partial digests indicating that 
these samples contain a mixture of wildtvpe (88 bp f  41 bp)and mutated sequences (129 
bp). Lanes 2,4,9 show complete cutting of the 129 bp band into 88 and 41 bp fragments 
indicating that the mismatch has been repaired back to wildtvpe. Lanes 5 + 8 contain 
samples which have remained undigested by Nael indicating the presence of only a 
mutated sequence at codon 12 of H-ras.
(v) Sequencing
As determined by the Nael digest, each sample to be sequenced was first prepared by 
treatment with the enzymes SAP (Shrimp Alkaline Phosphatase, USB Corporation) and 
Exol (USB Corporation). A 20 (j.1 aliquote of each PCR reaction was incubated with 10 
units of each enzyme for 15 minutes at 37°C followed by 15 minutes at 80°C to inhibit 
further enzyme activity. The samples were subsequently cleaned using the Qiagen PCR 
Purification Kit as described by the manufacture. These procedures combined remove 
excess salt, unincorporated dNTP’s and primer DNA from the PCR reaction mix and 
results in an improved sequencing reaction.
Cycle sequencing was performed using the radiolabeled primer cycle sequencing 
protocol from Amersham’s Thermo Sequenase cycle sequencing kit (Amersham 
Pharmacia Biotech Inc.). For each reaction the same 3’ H-ras primer used in the PCR 
reaction was 5’end labeled with [y]-32p ATP (6000 Ci/mMol, NEN Life Sciences Inc.) 
using T4 polynucleotide kinase as described by the manufacturer. The sequencing 
reaction was set up according to manufacturers instructions but with the following 
amended cycling parameters: (a) 96°C for 2 minutes, (b) {96°C 1 minute, 68°C for 30 
seconds, 72°C 1 minute} for 60 cycles. The sequencing products were loaded on a 12% 
polyacrylamide gel (19:1 acrylamide to bisacrylamide) and run for 3 hours at 2200 Volts. 
The gel was then fixed in 20% methanol: 20% acetic acid dried and exposed overnight at 
-70°C to X-ray film (Eastman Kodak Corporation). The exact sequence at codon 12 
could then be read from the developed film (Figure 7).
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1 2 3
G C A T  G C A T  G C A T
Codon 6
Codon 12
Codon 15
Figure 7
Mismatch repair analysis; example of a Polyacrylamide Sequencing gel 
autoradiograph.
All three samples contain +H/B samples as is indicated by the sequences at codon 6: (3’ 
GAA) and codon 15: (3‘ GAA). Lane 1 shows a wild-type sequence at codon 12 (3' 
CCG).
Lane 2 shows a mutated sequence at codon 12(3’ CAG), that resulted from the incorrect 
repair of a G/A mismatch. Lane 3 contains a mixture of wildtvpe and mutated sequences 
at codon 12 3'(C C/AG)
PART II: Effects o f  p,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot
Section I: Preliminary experiments to investigate the toxicity o f  environmentally relevant 
concentrations o f  p,p '-DDE on two immature mammalian cell types
A. p,p '-DDEpreparation
p,p  ’-DDE (hereafter DDE) stock solution was prepared by dissolving the chemical in 
acetone to a final concentration of 125 ng/|il. DDE working solution was then prepared 
by diluting the stock solution to a final concentration o f 1.25 x 10'3 (ig/fil with deionized 
water. For this study, the average cord blood concentration o f DDE (0.35 ^g/1) was 
designated the IX DDE treatment. As well, concentrations corresponding to ten (10X) 
and one hundred times (100X) the average cord blood levels were included. Therefore, 
DDE working solution was added to the cell culture media to a final concentration of:
0.35 (ig/1 (IX), 3.5 jj.g/1 (10X) or 35 ng/1 (100X). Control cells were treated with the same 
final amount of acetone per liter of media as IX treated cells (2.8 X 10'5 til acetone per 
10 ml media) and in the text are referred to as acetone alone or control samples.
B. Short-term assays o f chemical toxicity
(i) Assay fo r  changes in cell number
At specific time intervals, after the initiation of chemical exposure, the number of cells 
per sample was assayed to determine if DDE treatment resulted in any detectable changes 
in cell quantity. Both cell types were plated in duplicate at 5 x 105 cells per 10 cm dish. 
12-15 hrs later the cells were fed with media supplemented with acetone alone (control).
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or DDE at IX (0.35|ig/l) or 1 OX (3.5 fj.g/1) concentrations. At 2 hr intervals the media 
was removed and the plates immediately frozen at -20°C. The DNA quantity per sample 
was assessed by fluorescence using the diaminobenzoic acid (DABA) assay (240). The 
fluorescence of known numbers of cells was determined and subsequently used to 
convert DNA quantity per sample into number o f cells per sample.
(ii) Cell viability (Trypan blue) assay
The trypan blue assay of cell viability was performed to elucidate if the decreases in cell 
number observed in the DABA assay were caused by cell death. Both cell types were 
plated in duplicate at 1.0 x 106 cells per 15 cm dish. 12-15 hrs later the cells were fed 
with media containing either acetone alone (control) or DDE at IX or 10X 
concentrations. At 2, 4 or 6 hours duplicate plates of each cell type were trypsinized and 
re-suspended in Hank’s buffered saline solution (HBSS) (an additional 12 hour time- 
point was included for NIH 3T3 cells). Non-viable cells were identified by their 
permeability and subsequent staining with 0.4% trypan blue solution (241). At least 1000 
cells per treatment were microscopically examined and the number of dead cells (blue) 
expressed as a percentage of the total number of blue and unstained cells counted.
(in) Assays fo r  total glutathione (GSH -  GSSG) and reduced glutathione (GSH)
Total glutathione levels (GSH + GSSG) were measured to determine if exposure to IX or 
10X DDE resulted in significant alterations in the overall concentration o f this 
multifunctional cellular component. Reduced glutathione levels (GSH) were also 
measured to determine if the same DDE exposures resulted in significant changes in the 
oxidation state of glutathione.
(a) Assay fo r  total glutathione {GSH -  GSSG}
A modification of the Tietze assay (242, 243) was used to determine total glutathione 
levels in cells exposed to acetone alone (control), IX or 10X DDE. In this assay, GSSG is 
reduced to GSH by glutathione reductase in the presence of NADPH. Reduced GSH is 
then oxidized by 5,5’- dithiobis (2-nitrobenzoic acid) (DTNB) to form GSSG and 5-thio- 
2-nitrobenzoic acid (TNB). The rate of TNB formation is proportional to the sum of GSH 
and GSSG present in the sample and is monitored spectrophotometrically at 412 nm.
(b) Assay fo r  reduced glutathione {GSH}: Reduced glutathione was measured using the 
Bioxytech GSH 400 colorimetric assay as per the manufacturer’s protocol (OX1S 
International Inc.).
For each assay, both cell types were plated in duplicate at 5 x 105 per 10 cm dish. 
12-15 hrs later the cells were exposed to media supplemented with either acetone alone 
(control) or DDE at IX or 10X concentrations for 2, 4 or 6 hours (an additional 12 hour
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time-point was included for NIH 3T3 cells). At each time-point, duplicate plates for each 
assay were rinsed with phosphate buffered saline (PBS), trypsinized and pelleted by 
centrifugation for 5 minutes at 200 x g at 4°C. The amount o f protein per plate was 
quantified by the Bradford assay (238). Total and reduced glutathione were assayed as 
described above. Standard curves were prepared for each assay and were used to 
determine the amount of total or reduced glutathione per milligram protein o f each 
sample. Quantities of both total and reduced glutathione are expressed as a percentage of 
the control levels assayed at the same time-points.
(iv) DNA damage assay
The Comet assay (244), with minor alterations as described below, was used to assess if 
exposure to DDE resulted in DNA damage. Briefly, cells were plated in duplicate at 1.0 x 
106 on 15 cm dishes each containing 3 sterile frosted slides (Erie Scientific Co.). 12-15 
hrs later the cells were exposed to media supplemented with either acetone alone 
(control) or DDE at IX or 10X concentrations. Four hours after the addition of DDE the 
plates were rinsed twice with PBS and the glass slides were prepared for use in the Comet 
assay.
75 |al of 0.5% 3 1 agarose (Ameresco) in physiological saline was spread onto 
each slide, covered with a coverslip and placed on ice in the dark for 10 minutes. Then 
100 1^ of agarose solution was layered on top of the first, covered with a coverslip and 
placed on ice for an additional 10 minutes. When the agarose had solidified, the coverslip 
was removed and the slides immersed overnight in ice-cold lysing solution (2.5 M NaCl,
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1% N-lauroyl sarcosinate, 100 mM EDTA, 10 mM Tris (pH 10.0), 0.1 ng/ml Proteinase 
K and 1% Triton X-100). The slides were then incubated in alkaline electrophoresis 
buffer (300 mM NaOH, 0.1% 8-hydroxyquinoline and 10 mM EDTA) for 20 minutes at 
room temperature, after which time current was applied to the chamber at 22 V for 20 
minutes. The slides were then rinsed in 1 M ammonium acetate in ethanol for 30 minutes, 
drained and covered in 100% ethanol for 2 hours and lastly rinsed with 70% ethanol for 5 
minutes.
Pre-stain (5% DMSO, 30 mM NaH 2P0 4  and 5% sucrose) was added to each slide 
followed by 1 (iM YOYO-1 fluorescent stain (Molecular Probes). The slides were 
examined and photographed with an Axiovert 35 microscope (Zeiss, West Germany) 
equipped with a 35 mm camera and an FITC filter with a wavelength combination of: 
excitation at 490 nm, dichromic at 500 nm and emission at 515 nm. The total DNA length 
(displacement from the leading edge of the nucleus to the end of the tail) of each nucleus 
from a minimum of 50 cells per treatment was measured using the developed film.
(v) Cell cycle kinetics assay
This assay was performed to determine if exposure o f proliferating cells to DDE resulted 
in cell cycle fluctuations. Fluorescent activated cell sorting (FACS) cell cycle kinetic 
analysis was performed in the laboratory o f Dr. Peter Rabinovitch, Dept, of Pathology, 
University of Washington, Seattle WA. Specifically, measurement of the G l, S and 
G2/M compartment distributions was performed by flow cytometric analysis of BrdU (5- 
bromo-deoxyuridine) quenched Hoescht dye fluorescence (236).
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Each cell type was plated in triplicate at 5 x 105 per 10 cm dish. 12-15 hrs later the cells 
were treated with media containing 1.0 x lO^M BrdU and 50 fiM deoxycytidine plus 
either acetone alone (control), IX or 10X DDE concentrations. At intervals of two hours 
the plates were rinsed with PBS and trypsinized into media containing 10% DMSO for 
storage at -20°C. The samples were then shipped on dry ice to the University of 
Washington where FACS analysis was performed (as described previously).
C. Long-term assays o f  chemical toxicity
(i) Colony form ing ability
This assay was performed to determine if exposure to DDE affected the long-term 
survival of NIH 3T3 and WS1 cells, and consequently their ability to form colonies. 
Survival o f each treatment concentration is expressed as a percentage o f the number of 
colonies formed on the control plates. 800 cells were plated for each WS1 experiment 
and 200 cells for each NIH 3T3 experiment in duplicate on 15 cm dishes. 12-15 hrs later 
the cells were fed with media containing either acetone alone (control) or DDE at IX or 
10X concentrations. The cells were allowed to grow for an additional 12-14 days in the 
DDE containing media without refeeding, at which time the colonies were visualized by 
staining with 0.5% crystal violet in 20% ethanol. Colonies containing 50 or more cells 
were counted and percent survival was calculated as the average number of colonies for 
each concentration of DDE relative to acetone alone (control) plates. Each colony 
forming experiment was repeated at least three times and the average of three 
independent experiments was determined for each cell type.
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(ii) Transformation assay: This assay was performed to determine if exposure to DDE 
had an effect on the number of transformed foci formed by NIH 3T3 cells (245). NIH 
3T3 cells were plated at 3 x 105 cells per 10 cm plate. 12 -15 hours later the cells were 
treated as described with media containing, either acetone alone (control), 1X, 1 OX or 
100X DDE and subsequently refed biweekly for four weeks with fresh DDE containing 
media. The cells were then fixed with 97% methanol and stained with 0.5%  crystal violet 
in 20% ethanol. The number of darkly staining foci on each plate was counted and 
comparisons were made between the numbers o f foci found on the control, IX, 1 OX and 
100X plates.
(Hi) Statistical analysis: Data values are expressed as the mean ± SD where appropriate. 
Mean values were considered to be statistically different when the probability value P 
was less than 0.05 as calculated by one-way analysis o f variance (ANOVA) and 
Scheffe’s comparisons.
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Section II: Effects o f  environmentally relevant concentrations o f  p,p ’-DDE on mismatch 
repair at an oncogenic hot-spot
In order to study mismatch repair in WS1 cells it was necessary to devise a protocol that 
would discriminate between the site-specifically mismatched H-ras plasmid and the 
human chromosomal H-ras sequences from the human cells. All of the site-specific 
mismatch experimental preparation steps were carried out as described in Part I except 
that the final vector into which the 1.8 kb fragment was ligated was not capable of 
replicating in mammalian cells (pbc-Nl; see below). After transfection the plasmid was 
extracted from the cells, transformed into mismatch deficient bacteria (NR9374) and the 
plasmid was subsequently isolated from individual colonies. Mismatch repair rates were 
determined in the same manner as in Part I and, because the bacteria are mismatch repair 
deficient and the mismatched plasmid is incapable of replication in the eukaryotic cells, 
the repair results obtained are a direct representation of the mammalian cells mismatch 
repair capability.
A. Plasmid and M l3 constructs
The plasmid pbc-Nl (10.7-kb) was purchased from American Type Culture Collection 
(ATCC) and consists of 6.4-kb of human genomic H-ras inserted into the BamH\ site of 
pBR322 (244). The resulting plasmid differs from the p220.pbc plasmid in a number of 
ways. Pbc-N 1 lacks a viral origin of replication, making this plasmid incapable of 
replication in mammalian cells. However, pbc-N 1 retains all of the other elements 
necessary to construct site- and strand-specific mismatches at codon 12 of W-ras. All
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other vectors used in the construction of site- and strand-specific mismatched pbc-N 1 
were as described in materials and methods Part I.
B. Mismatch construction
(i) Fragment preparation; (ii) Oligonucleotides; (iii) M elt and reanneal; (iv) Isolation o f  
the 1.8 kb fragment; As described in Part I except only G:A and G:T mismatches were 
constructed (see also Figure 5).
(v) Final assembly o f  the site- and strand-specific mismatched pbc~Nl plasmid 
Vector preparation. The pbc-N 1 plasmid was digested with 20 units each of Xho\ and 
Kpnl per |ig DNA at a final DNA concentration of 100 ng/^il. The reaction products were 
subsequently separated by electrophoresis at low voltage on a 0.8% SeaKem GTG (FMC 
Bioproducts) agarose gel. The 8.9 kb band was excised, recovered using the Qiaquick Gel 
Extraction Kit as described by the manufacturer (Qiagen Inc.) and quantified. This 
purified segment contained the remaining H -ras genomic sequence (minus the 1.8 kb 
fragment surrounding codon 12), bacterial carbenicillin resistance and bacterial 
replication sequences.
Annealing and ligation: To ensure that the mismatch-containing oligonucleotide 
was indeed present, excess mismatch-containing oligonucleotide was annealed to the 1.8 
kb fragment as described. Phosphorylated oligonucleotide and the 1.8 kb fragment were 
mixed together at a 200:1 molar ratio of oligonucleotide: 1.8 kb fragment at a DNA 
concentration of 30 ng/(il in a buffer consisting of 50 mM Tris-HCL pH 7.6, 10 nM
dithiothreitol and 500 |ig/ml bovine serum albumin. The mixture was placed in a 2-liter 
beaker containing 85-90°C water and allowed to cool slowly to room temperature. The
1.8 kb fragment was then ligated to the 8.9 kb XhoVKpnl pbc-N 1 vector at a 2:1 molar 
ratio of fragment to vector using 0.5 units T4 DNA Ligase per |ig DNA as described by 
the manufacturer (Boehringer Mannheim) This final ligation step produced a 10.7 kb 
pbc-Nl plasmid containing a site- and strand-specific mismatch at H-ras codon 12 
middle base pair position. In addition the plasmid containing the mismatch could easily 
be distinguished from wildtype plasmid by the presence of the Hindlll and Bst 981 sites 
as described in Part I..
C. Transfection o f  DDE treated NIH 3T3 and WS1 cells with mismatched plasmid 
NIH 3T3 and WS1 cells were seeded at 5 x 105 cells per 10 cm plate. One hour prior to 
the start o f transfection each plate was re-fed with fresh media containing 1 OX DDE (or 
media alone for all DDE negative plates) and returned to the incubator.
Both cell types were transfected with 300 ng of G/A or G/T mismatched pbc- 
Nl+H/B plasmid. Transfection was carried out using Lipofectamine reagent at a 100:1 
ratio of liposome to DNA as described by the manufacturer (Life Technologies). Each 
plate was rinsed with 5 mis of IX PBS. To each plate 4 mis o f OptiMem was added as 
well as 10X DDE to all DDE treated plates, followed by the addition of the liposome: 
DNA mixture. The plates were then placed on a rotator for 30 minutes at 37°C followed 
by a further 5 Vi hour incubation at 37°C in 5% CO2 without agitation. At the end of this
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transfection period each plate was fed with fresh media, containing 1 OX DDE where 
appropriate, and returned to the incubator for a further 24 hours.
D. Mismatch repair analysis
(i) Cell harvest and plasmid extraction
At the end of the 24-hour incubation period the cells on each plate were harvested by 
trypsinization (as described above) and pelleted by centrifugation at 200 x g for 5 
minutes. The plasmid DNA was recovered from the cell pellet using the Quantum Prep 
Plasmid Miniprep kit as described by the manufacturer (Biorad Laboratories Inc )
(ii) Transformation ofNR9374 mismatch repair deficient bacteria
NR9374 competent bacteria were prepared by the following method. NR9374 bacteria 
from a glycerol stock were grown overnight at 37°C on a LB agar plate containing 30 (ig 
per ml of kanamycin. NR9374 colonies were then transferred to SOB medium (2% 
Bacto-tryptone, 0.5% bacto yeast extract, 2.5 mM MgCh, 0.85 mM NaCl) and incubated 
with shaking at 37°C. After 3 hours the optical density at 550 nm was checked with an 
OD 5 50 o f 0.5 indicating a cell density of 5 x 107 cells/ml. Cells were grown until they
7 8reached a density o f at least 1 x 1 0  cells/ml but were not permitted to exceed 1x10  
cells/ml. The cultures were then cooled on ice for 10 minutes, followed by centrifugation 
at 2500 x g for 10 minutes. The cell pellets were then re-suspended in FSB solution (pH 
6.4) (10 mM potassium acetate pH 7.5, 45 mM MnC12, 10 mM CaCI2 , 100 mM KCL, 3 
mM Hexamminecobalt chloride, 10% glycerol), placed on ice for 10 minutes and then
centrifuged at 2500 x g for 10 minutes. Finally, each cell pellet was re-suspended in 4 mis 
ofFSB.
Purified plasmid extracted from each plate o f mammalian cells was then added to 
200 (il of freshly prepared NR9374 competent cells. Each solution was incubated on ice 
for 30 minutes, followed by 90 seconds at 42°C and a further 2 minutes on ice. 800 jj.1 of 
SOC (SOB and 20 mM glucose) was added to each solution and placed in a 37°C shaking 
incubator for 60 minutes at 225 rpm. The bacterial solutions were then spread on LB 
agar/carbenicillin (100 (ig/ml) plates and grown overnight at 37°C.
(iii) Mini-preparations and DNA extraction from  individual NR93 74 colonies 
Individual NR9374 bacterial colonies from (ii) were plucked with a sterile toothpick and 
placed in 2-mls of LB broth and 100 ug/ml carbenicillin and grown overnight at 37°C in 
a shaking incubator. The pbc-N 1 plasmid was then purified from the bacterial culture 
using the Wizard Plus SV Miniprep DNA Purification System as described by the 
manufacturer (Promega Corporation Inc.).
(iv) PCR amplification
A 10 j j .1 aliquot from each DNA isolate was PCR amplified with 2.5 units of AmpliTaq 
Gold (Applied Biosystems) in the supplied buffer plus 3 .5 mM MgCb, 200 |iM of each 
dNTP and 100 ng of each primer in a final volume of 100 (j.1, with the enzyme separated 
from the other reactants by a wax layer (Chill-Out 14, MJ Research, Inc.). The reactions 
were heated to 95°C for 9 minutes followed by 30 seconds at 95°C and 1 minute at 61°C
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for 30 cycles. Finally, the samples were incubated for 10 minutes at 61°C to allow 
completion of extension reactions and cooled to 4°C The primers used for the PCR 
reaction were as described in Part I; Materials and methods.
(v) Contamination check o f  amplified H-ras segment
Each PCR amplified sample was tested to confirm that it did not result from transfection 
of undigested vector (pbc-Nl-H/B) as described Part I; Materials and methods (Figure 6,
B).
(vi) Mismatch repair analysis
A 20 (j.1 aliquot of each +H/B amplified PCR product was digested with 4 units o f Turbo 
Nae\ as described in Part I; Materials and methods (Figure 6, C).
(vii) Sequencing
Sample cleanup and sequencing were carried out as described in Part I, Materials and 
methods.
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m . RESULTS
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized mammalian cells
Section I: Gi synchronization, fluorescent activated cell-sorting analysis, plasmid 
replication kinetics and mismatch repair protein expression in Gi nuclear extracts
A. Gi synchronization and fluorescent activated cell-sorting analysis (FACS).
To examine the activity of the mismatch repair system in the Gi phase o f the cell cycle it 
was necessary to find a method of cell synchrony whose effects were fully reversible but 
which synchronized the majority of cells in the Gi phase of the cell cycle. In previous 
investigations serum starvation has been found to be the most reliable method to achieve 
both of these goals with NIH 3T3 cells (Personal communication from Dr. Peter 
Rabinovitch, University of Washington).
FACS analysis was used to determine the percentage of NIH 3T3 cells in Gi after 
3 days o f growth in 0.25% CS/DMEM and for the 24 hours following replacement with 
media containing 10%CS/DMEM on day 4 at 0 hours. Re-feeding with 10% CS reversed 
the effects of serum starvation and allowed the cells to re-enter the cell cycle (235).
As shown in Table 3 over 96% of the cells were in Gi on day 4 at 0 hr when re­
feeding took place (Published in 54). In addition, greater than 96% of the cells remained 
in Gi for up to 12 hours after re-feeding. From 12 hours onwards the percentage of cells 
in Gi decreased, indicating that the cells had successfully progressed to succeeding stages 
of the cell cycle. In fact, plates of re-fed Gi synchronized cells regained normal growth 
rates and reached confluence, albeit at a later time than control plates (data not shown).
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Table 3: Percentage of NIH 3T3 cells in the Gi phase of the cell cycle with and
without serum starvation
Percentage o f cells in Gia
Day and 
Time Serum Starved C ontrolc
harvested b
Day 2 85.2% 55.2%
Day 3 94.3% 63%
Day 4, 0 hr 96.8% 74.7%
Day 4, 2 hr 96.9% nd d
Day 4, 4 hr 96.7% nd
Day 4, 6 hr 97.8% nd
Day 4, 8 hr 98% nd
Day 4, 10 hr 97.9% 50.9%
Day 4, 12 hr 97.5% 45.3%
Day 4, 14 hr 78.8% nd
Day 4, 16 hr 52.3% nd
Day 4, 18 hr 8.4% 50.7%
Day 4, 20 hr 9.6% nd
Day 4, 22 hr 22.7% nd
Day 4, 24 hr 38.8% 68.7%
a Percentage of cells in Gi was determined by fluorescence 
activated cell sorting (FACS). Plates for each time point were 
collected in duplicate.
b Cells were serum starved in 0.25% calf serum/DMEM 
beginning on Day 1. On Day 4 at 0 hr, this media was replaced 
with 10% calf serum/DMEM.
c Control cells were grown in 10% calf serum/DMEM.
This media was replaced with fresh 10% calf serum/DMEM 
on Day 4 at 0 hour.
d nd = not determined. Published in Matton et al 1999 (54).
B. Plasmid replication kinetics
Plasmids derived from the Epstein Barr virus have been shown to replicate autonomously 
once per cell cycle in human and simian cells (247). However, it is unknown if this 
occurs in murine cells and whether cell cycle synchronization also affects plasmid 
replication. We examined the replication kinetics of the p220.pbc-H/B plasmid in NIH 
3T3 cells in order to determine if and/or how Gi synchrony affected plasmid replication. 
The restriction enzyme Dpnll was used to compare plasmid replication in Gi 
synchronized and actively growing cells. Digestion of DNA by D pnll is blocked by 
prokaryotic adenine methylation, therefore, only those plasmids that had replicated in 
mammalian cells were sensitive to digestion. Digestion reactions were southern blotted 
and hybridized with a 613 bp radioactive probe prepared from the p220.pbc -H/B 
plasmid.
The results o f the plasmid replication kinetics study in NTH 3T3 cells are shown 
in Figure 8. Because unreplicated plasmid DNA within mammalian cells remains 
undigested by Dpnll, the radioactive probe hybridizes to the whole plasmid and results in 
the appearance of a radioactive band at 15 .3 kb corresponding to the size of the uncut 
plasmid. In contrast, replicated plasmid DNA is digested by Dpnll to produce 45 smaller 
fragments o f which the sequence corresponding to the radioactive probe is contained in a 
fragment also o f size 613 bp. As a control p220.pbc-H/B plasmid was digested with Dpnl
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Figure 8: Plasmid replication kinetics
Actively proliferating (A) and Gi synchronized (B) NIH 3T3 cells were 
transfected with plasmid DNA. At various time-points, the plasmid was 
recovered, digested with Dpnll to detect replicated plasmid DNA and hybridized 
with a radioactively labelled 613 bp fragment of p220.pbc plasmid (see materials 
and methods). Replication o f the plasmid DNA in mammalian cells is visualized 
by the appearance of a 613 bp radioactive band on the autoradiogram.
(A): In actively proliferating cells, replicated plasmid is detected by 12 hours after 
transfection, lanes 9-14 (duplicate plates harvested at each timepoint). (B): In Gi 
synchronized cells , replicated plasmid is not detected until 96 hours after 
transfection or 97 hours after refeeding with 10%CS/DMEM (lanes 34 + 35), 
illustrating that in cell cycle arrested cells there is a significant delay in the 
replication of the plasmid DNA.
enzyme. This enzyme cuts at the same restriction sites as D pnll but cuts only DNA with 
adenine methylation produced by prokaryotic replication.
In actively proliferating control cells the 613-bp band, indicating plasmid replication, is 
clearly detected by 12 hours after transfection (Figure 8A, lanes 9 -14). In contrast, in Gi 
synchronized cells the 613 bp band is seen for the first time in cellular extracts 96 hours after 
transfection or 97 hours after refeeding with 10% CS/DMEM took place (Figure 8B, lanes 34 +35). 
These results show that replication of the extrachromosomal p220.pbc-HZB plasmid is delayed for a 
substantial period in G] synchronized NIH 3T3 cells as compared to proliferating cells. Thus, this 
EBV plasmid does indeed appear to replicate synchronously with the murine cell cycle. Therefore, if 
mismatch repair is active in these cells during Gi there should be sufficient time for repair to occur 
before replication of the plasmid DNA could take place.
C. Mismatch repair protein expression in Gj nuclear extracts
As discussed in the introduction, the mismatch repair system is not the sole method of 
DNA repair available to mammalian cells. In addition mismatch repair has been 
historically designated a “post-replicative” DNA repair mechanism because of initial 
discoveries and studies using the E.coli system. This assay was performed to determine if 
a particular mismatch protein could be detected in nuclear extracts from Gi synchronized 
mammalian cells. Although not necessarily an indicator o f activity, the presence of the 
protein would provide additional evidence that mismatch repair is active in the Gi phase 
of the mammalian cell cycle. At the time when these experiments were performed 
hMSH2 was the only commercially available antibody that could also be used with
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mouse cellular extracts and it was for this reason that it was the only MMR protein 
probed for in NIH 3T3 Gi extracts.
Nuclear and cytoplasmic extracts were prepared from Gi synchronized 
populations of NIH 3T3 cells. The preparations, containing equal amounts of total 
protein, were subsequently Western blotted for the presence o f the MSH2 mismatch 
repair protein and the results are shown in Figure 9. It is clearly shown that the full length 
102-kDa MSH2 protein is present in both Gi nuclear and cytoplasmic extracts (Figure 9. 
Lanes 1 and 3). In addition, the protein appears to be present in relatively similar amounts 
in both Gi and non-synchronized cytoplasmic (lanes 1 + 2) and nuclear extracts (lanes 3 
+ 4).
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Figure 9: Western blot of NIH 3T3 Gi nuclear and cytoplasmic extracts
Gi synchronized NIH 3T3 nuclear and cytoplasmic extracts were subjected to a Western 
blot to detect the mismatch repair protein MSH2 (102 kDa indicated by arrow) (see 
materials and methods). MSH2 is present in relatively equal amounts in both Gi nuclear 
and cytoplasmic extracts as compared to non-synchronized extracts prepared by the same 
method. L ane 1: 40 (o.g NIH 3T3 Gi cytoplasmic extract. L an e 2: 40 (j.g NIH 3T3 non 
synchronized cytoplasmic extract; L an e 3: 40 Gi nuclear extract; L an e 4: 40 (ig non- 
synchronized nuclear extract; L an e 5: Molecular weight marker.
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Section II: Mismatch repair in the Gi phase o f  the mammalian cell cycle 
A. Mismatch repair rates at codon 12 o f  H-ras in Gi synchronized cells 
The repair rates of four specific mismatches at the middle nucleotide position of H-ras 
codon 12 contained within the p220.pbc plasmid and transfected into NIH 3T3 Gi 
synchronized cells are shown in Table 4. We observed almost complete correct repair of 
all four mismatches, (G:T = 92%, G:A = 100%, A:C = 100%, T:C = 100%). Intriguingly, 
Gi synchronization was the only experimental situation in which we observed an instance 
of incorrect repair that resulted in a mutation at codon 12 (G:T —» A:T) (see Table 4). As 
well, because of the extended time in Gi none o f the mismatches were replicated before 
mismatch repair occurred, which resulted in a lack o f samples containing wild type and 
mutated sequence mixtures or unrepaired replicated mismatches. This is a dramatic 
difference from results obtained from non-synchronized cell experiments where mixtures 
were found; G:T = 0%, G:A = 65%, A:C = 42%, T:C = 20% (53).
Each mismatch preparation was prepared at least twice and also transformed into 
DH5a E.coli as a control. It has been previously demonstrated by this laboratory that 
codon 12 of H-ras is not a hotspot o f mutation in these bacteria (53). Comparison of the 
Gi results with DH5a mismatch repair results (Table 5) indicate that E.coli have a correct 
repair rate that is similarly high or higher than the Gi synchronized NIH 3T3 cells (with 
the exception of G/A which is repaired more accurately in NIH 3T3 Gi synchronized 
cells). These results further confirm that H-ra.v codon 12 is not a hotspot o f mutation for 
DH5a E.coli.
   .. v: W’/-
v~i'AIRB<-oliCSUNIVERSiiY w  , .
Previously, this laboratory determined in vivo rates o f repair for G:A, G:T, A:C and T:C 
mismatches at the middle nucleotide position of Yi-ras codon 12 in non-synchronized 
NIH 3T3 (53). Figure 10 shows a comparison between repair rates in our recent Gi 
synchronized and previously determined non-synchronized NIH 3T3 cells. Repair of 
mismatches in Gi cells was almost always correct (see Table 4), compared with rates as 
low as 35% for the G:A mismatch at codon 12 in non-synchronized cells (53). These 
results indicate that DNA mismatch repair mechanisms are active and highly accurate 
during the Gi stage of the mammalian cell cycle. It is important to note that our Gi 
synchronized cells had significant amounts o f time to repair the mismatched DNA before 
entering S-phase, while in non-synchronized cells, the amount of time available for repair 
is quite variable. These results show that given enough time before replication, NIH 3T3 
cells have a significantly increased capacity to correctly repair all mismatches tested at 
the codon 12 W-ras oncogenic hotspot.
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Table 4: M ismatch repair at codon 12 of H-ras in Gisynchronized NIH 3T3 cells
NIH 3T3 G, 
MISMATCH
Ccrrectlv 
repaired 
mismatch => 
G:C 
(Total 
Assayed)
Incorrectly 
Repaired 
Mismatch to 
T. A or A T 
(Total 
Assayed)
Unrepaired 
Mismatch => 
G:C / T:A or 
G.C / AT 
(Total 
Assayed)
G:T 92% 8% 0%
(12/13) (1/13) (0/13)
G:A 100% 0% 0%
(27/27) (0/27) (0/27)
A:C 100% 0% 0%
(18/18) (0/18) (0/18)
T:C 100% 0% 0%
(21/21) (0/21) (0/21)
3 Greater than 96% of cells were in G,. as determined by FACS analysis.
see results and Table 3. Published in Matton et al 1999 (54).
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Table 5: Mismatch repair at codon 12 of H-ras in DH5a E.coW
DH5a E.coli Correctly Incorrectly Unrepaired
MISMATCH repaired Repaired Mismatch =>
mismatch => Mismatch to G:C / T:A or
G:C T:A or A:T G:C / A:T
(Total (Total (Total
Assayed) Assayed Assayed)
G:T 95% 5% 0%
(42/44) (2/44) (0/44)
G:A 89% 3% 8%
(65/73) (2/73) (6/73)
A:C 97% 0% 3%
(38/39) (0/39) (1/39)
T:C 100% 0% 0%
(35/35) (0/35) (0/35)
3 A portion of each mismatch preparation used in the NIH 3T3 studies was used 
to transform mismatch proficient E.coli (DH5a) as a control.
Published in Matton et al 1999 (54).
G/T G/A A/C T/C
Mismatch
H  Codon 12 -G1 Synchronized 
HO Codon 12 - Non-synchronized
Figure 10: Comparison of mismatch rates in Gi synchronized and non­
synchronized NIH 3T3 cells
Repair rates for codon 12 of H-ras in non-synchronized cells were reported by 
Arcangeli and Williams (234) and are shown here for comparison, (correct repair: 
G:T = 100%, G:A = 35%, A C  = 58%, T:C = 80%). Repair rates include only 
those mismatches repaired correctly to G:C but not mismatches which were 
replicated before repair and thus were found as mixtures in the resulting colony. 
Published in Matton et al 1999 (54).
PART II: Effects o f  p ,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot
Section I: Preliminary experiments to investigate the toxic effects o f  environmentally 
relevant concentrations o f DDE on two immature mammalian cell types.
A. Short-term assays o f chemical toxicity
(i) Assay fo r  changes in cell number
Figure 11 illustrates the effects over time of both IX and 10X cord blood concentration 
on the cell quantity of the two embryonic mammalian cell types. NIH 3T3 cells exhibit a 
small decrease in cell number in both IX and 10X DDE treated samples by 2-4 hours 
exposure as compared to acetone alone samples (hereafter controls) (Figure 11 A). In 
addition, there is a second decrease in cell number in comparison to controls by 12 hours 
exposure to 10X DDE. However, the results of subsequent assays (discussed below), 
consistently showed no significant differences between treated and control samples at 12 
hours exposure. We therefore conclude that this conflicting result from the DABA assay 
was due to either to sampling error or more subtle effects not detected by subsequent 
assays. At the next time-point tested, 24 hours, the number of cells on all plates is similar 
indicating that confluence has been reached and the cell population is at a maximum in 
all samples.
Unlike the NIH 3T3 controls, the WS1 control samples exhibit a decrease in cell 
number by 2 hours exposure to the treatment media (Figure 1 IB). We believe that this
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effect may simply be due to the mechanical effects o f media removal as these normal 
human cells are easily dislodged from the plate.
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Figure 11: Assay for changes in cell number
Effect of acetone alone (control), IX or 1 OX DDE and duration of exposure on the cell number of 
two cell types. NIH 3T3 (A) and WS1 (B) cell cultures were harvested in duplicate at the 
indicated time-points after the addition of media containing acetone alone (control), IX or 1 OX 
DDE. The total DNA from each plate was determined using the diaminobenzoic acid assay (see 
materials and methods). Cell numbers were calculated by comparison to the DNA quantities of 
known numbers of cells. The graphs represent the average number of cells per duplicate sample 
per time-point of harvest ± SD. Data points without error bars represent those duplicate samples 
in which the SD was too small to be represented on the graph. Published in Simonetti et al 2001 
(213).
Nonetheless, WS1 cells exposed to IX or 10X DDE for 2-4 hours exhibit an even greater 
decrease in cell number in comparison to controls. In contrast to the NIH 3T3 cells, we 
find neither a recovery to control levels or an additional depletion in WS1 cell number up 
to 24 hours exposure. At the next time-point tested, 72 hours, (not shown on graph), there 
is no significant difference between the number of cells on control, IX or 10X treated 
plates (mean = 8.3 x 106 cells per plate). This indicates that the cells in each treatment 
group have grown to confluence and are no longer dividing due to contact inhibition.
(ii) Cell viability (Trypan Blue) assay
The percentages of non-viable NIH 3T3 and WS1 cells that result from exposure to IX or 
10X DDE at 2, 4 or 6 hours are shown in Table 6. As compared to controls, there is a 
significant increase in the percentage o f non-viable NIH 3T3 cells after 2 and 4 hours 
exposure to both IX and 10X DDE (p < 0.05). However, at both 6 (Table 6) and 12 hours 
(data not shown) there is no significant difference between the amount of cell death found 
on control NIH 3T3 plates or those treated with IX or 10X DDE. WS1 cells treated with 
IX or 10X DDE for 2, 4 or 6 hours exhibit no increase in cell death as compared to 
controls.
(Hi) Assays fo r  total glutathione (GSH & GSSG) and reduced glutathione (GSH)
(a) Assay fo r  total glutathione (GSH -  GSSG)
The effects of IX and 10X DDE on the total glutathione levels o f NIH 3T3 and W S1 
cells are shown in Figure 12 [A and B],
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Table 6: Assay of cell viability (Trypan Blue)a
C ELL TYPE T R E A T M E N T PERCENTAGE  
NON-VIABLE CELLS  
n > 1000
2h 4h 6h
NIH 3T3 Control 2 .4% 9.3% 6 .0%
IX  DDE 6.4%* 13.9% 1 4 .4%
10X DDE 8.1%" 17.4% ‘ 5.8%
WS1 Control 5.6% 6.7% 5.8%
IX DDE 3.9% 6.3% 4 .6%
10X DDE 3.5% 6 .7% 4 .6%
a Non-viable cells were identified by their permeability to 0.4% trypan blue, 
as compared to viable cells which are impermeable to the dye (240).
The number of non-viable cells (blue) is expressed as a percentage (%) of 
the total number of cells counted (unstained and blue).
Total number of cells counted was > 1000 for all time-points and treatments. 
b Significant increase (p < 0.05) in cell death, by 2 hours of IX or 10X DDE 
treatment, as compared to NIH 3T3 control cells.
c Significant increase (p < 0.05) in cell death, by 4 hours of IX or 10X DDE 
treatment, as compared to NIH 3T3 control cells.
Published in Simonetti et al 2001 (213).
There are no significant differences, as compared to controls, in the total glutathione 
levels o f NIH 3T3 cells exposed to IX or 10X DDE for 2,4 or 6 hours (Figure 12A). In 
contrast, WS1 cells similarly treated exhibit significant differences in their total 
glutathione levels (Figure 12B) At 2 hours exposure, although IX DDE WS1 cells were 
not significantly different from controls, 10X DDE WS1 cells exhibit a large reduction in 
total glutathione levels as compared to controls (p > 0.05). By 4 hours exposure WS1 
total glutathione levels have increased significantly above controls in 1X DDE samples 
and have attained approximate control levels in samples exposed to 10X DDE. WS1 cells 
exposed to 1X DDE for 6 hours have returned to total glutathione levels similar to 
controls. In contrast, the total glutathione levels o f WS1 cells exposed to 10X DDE for 6 
hours have increased slightly but not significantly above control levels.
(b) Assay fo r  reduce J  glutathione (GSH)
The effects o f IX and 10X DDE on the reduced glutathione levels of NIH 3T3 and WS1 
cells are shown in Figure 12 (C and D). NIH 3T3 cells exhibit a significant increase in 
reduced glutathione at 4 hours exposure to 1X DDE, however, by 6 hours exposure there 
is no significant difference between the reduced glutathione levels of the 1X DDE treated 
and control samples (Figure 12C). In contrast, NIH 3T3 cells exposed to 10X DDE for 2 
hours show a significant decrease in reduced glutathione level as compared to controls. 
However, at both 4 and 6 hours (Figure 12C) exposure to 10X DDE there is no 
significant difference in glutathione levels as compared to controls
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Figure 12D illustrates the results of the reduced glutathione assay for WS1 cells exposed 
to IX or 10X DDE for 2, 4 or 6 hours. The reduced glutathione content of WS1 cells 
treated for 2 hours with IX DDE is significantly increased above that of control 
cells. By 4 hours exposure to IX DDE the reduced glutathione content is only 50% of the 
control level, but by 6 hours exposure to IX DDE reduced glutathione levels have 
rebounded back to control levels. WS1 cells exposed to 10X DDE for 2 hours exhibit a 
slight but not significant increase in reduced glutathione level as compared to controls.
By 4 hours the 10X DDE exposed WS1 cells exhibit a significant decrease in reduced 
glutathione levels as compared to controls. By 6 hours the reduced glutathione level of 
10X DDE treated WS1 cells have rebounded and are significantly increased above 
control levels.
110
I l l
TOTAL GLUTATHIONE (GSH + GSSG)
(A) NIH 3T3 (B) WS1
20 0  - |
T □
2 HOURS
4 HOURS
6 HOURS
IX DDE 10X DDE IX  DDE 10X DDE
REDUCED GLUTATHIONE (GSH)
(C) NIH 3T3 (D) WS1
IX DDE 1 OX DDE
□  2 HOURS
m  4 HOURS 
[HD 6 HOURS
Figure 12: Assays for total glutathione {GSSG + GSH} and reduced glutathione 
{GSH}
See following page for legend.
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Figure 12: Legend
Effect of IX and 10X DDE on the total cellular glutathione levels within (A) NIH 3T3 
and (B) WS1 and reduced glutathione levels within (C) NIH 3T3 and (D) WS1.
NIH 3T3 and WS1 cells were plated in duplicate and treated with acetone alone (control), 
IX or 10X DDE for the times indicated. Cells were subsequently harvested by 
trypsinization and pelleted. Total glutathione concentration per mg protein was measured 
using the Tietze method (241, 242). Reduced glutathione concentration per mg protein 
was determined using the Bioxytech GSH 400 kit as per the manufacturer’s instructions. 
The data points represent the average total or reduced glutathione levels expressed as a 
percentage of the total or reduced glutathione concentration per mg protein in control 
samples measured at the same time-points. Asterisk * indicates a significant difference 
from acetone alone (control) by one-way ANOVA (p > 0.05). Published in Simonetti et 
al 2001 (213).
The Comet assay (244) was performed to determine if exposure to IX or 10X DDE 
resulted in DNA damage. When assayed by alkaline electrophoresis, DNA damage, 
specifically single-strand breaks, results in an increased displacement between the 
leading edge o f the nucleus and the end o f the tail (comet) and is expressed as an increase 
in total DNA length, (see Figure 13 for example). Table 7 contains the average 
measurements o f the total DNA lengths o f WS1 and NIH 3T3 cells exposed to acetone 
alone (control), IX or 10X DDE for 4 hours.
When compared to controls, there was a significant increase in NIH 3T3 total 
DNA length after 4 hours exposure to both IX and 10X DDE (p < 0 05) although the IX 
and 10X lengths are not significantly different from each other. In contrast the total DNA 
lengths of WS1 cells treated with acetone alone (control), IX or 10X DDE for 4 hours are 
not significantly different from each other.
113
(iv) DNA damage assay
Figure 13: Comet assay
The Comet assay was performed to determine if exposure to DDE resulted in 
DNA damage. Within individual cells, damage to nuclear DNA results in the 
increased migration of DNA through agarose. Shown here are typical examples of 
the “Comet tails” formed by the DNA of NIH 3T3 cells exposed to Control (A), 
IX DDE (B) and 10X DDE (C) for 4 hours. See Table 7 for actual measurements.
Table 7: DNA damage assay (Comet assay) °
CELL TYPE TREATM ENT
4h
T O T A L  DNA  
L E N G T H  
A V E R A G E
N IH 3T3 Control 15.9 ±  14 mm
IX DDE 18.7 ± 1.76 mm*
10X DDE 19.7 ± 2 .7  mm*
WS 1 Control 14.7 ± 3 5 mm
IX DDE 14.6 ± 4 2 mm
10X DDE 14 .2 ± 3 3 mm
"The Comet assay (243) was performed to determine if 4 hours 
exposure to IX or 10X DDE resulted in DNA damage. Damage to 
nuclear DNA within individual cells, results in an increased ability 
of the DNA to migrate through agarose during electophoresis and is 
expressed as an increase in total DNA length. The total DNA length 
(the displacement between the leading edge of the nucleus and 
the end of the tail) of a minimum of 50 cells per treatment w as 
measured and the average length calculated + SD. 
b Significant increase (p < 0.05) in DNA migration, indicating 
increased strand breakage, as compared to NIH 3T3 control cells. 
Published in Simonetti et al 2001 (213).
(v) Cell cycle kinetics assay
The effects of IX and 10X DDE on the progression of WS1 and NIH 3T3 cells through 
the cell cycle are shown in Figure 11. FACS results reveal no significant difference 
between the number of cells entering S phase in the control, IX and 10X DDE treated 
NIH 3T3 cells at the time-points tested between 0 h and 30 h (Figure 14A).
Similar to NIH 3T3 cells, WS1 acetone alone (control) cells began to incorporate 
BrdU within 4 hours after it was added to the media (Figure 14B). In contrast, IX DDE 
treated WS1 cells did not begin to incorporate BrdU until approximately 6 hours after the 
initiation of DDE exposure. Furthermore, the IX DDE treated cells maintain the 2-hour 
lag in the number of cells entering S phase up to 30 hours after the chemical has been 
added. No data is available for WS1 cells treated with 10X DDE, as despite repeated 
attempts to obtain this information, this treatment group of cells could not survive the 
combined flow cytometric protocol and exposure to 10X DDE.
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(A) NIH 3T3
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1X DDE 
10X DDE
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(B) WS1
CONTROL 
1X DDE
HOUR
Figure 14: Cell cycle kinetics assay
Cell cycle kinetics of NIH 3T3 and WS1 cells exposed to acetone alone (control). IX or 
10X DDE. NIH 3T3 (A) and WS1 (B) cells were exposed to media containing BrdU. 
deoxycvtidine and either acetone alone (control), IX or 10X DDE. Samples were 
harvested by trypsinization at the indicated time-points and underwent BrdU-Hoescht 
flow cytometric analysis. Data points representing WS1 cells exposed to 10X DDE are 
absent, as despite repeated trials, these cells could not survive both the cytometric 
protocol and DDE exposure. Published in Simonetti et al 2001 (213).
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Figure 15: Colony forming ability
Comparison of the effect of DDE on the long-term survival of NIH 3T3 and WS1 
cells exposed to acetone alone (control), IX or 10X DDE. Cells were plated in 
duplicate per treatment and grown in the presence o f DDE for 12-14 days. The 
cells were then fixed, stained and the number o f colonies counted per plate. Cell 
survival per treatment is expressed as a percentage o f the number of surviving 
colonies on the control plates. The graph represents the average percent survival 
from three independent experiments. Asterisk (*) indicates a significant difference 
from acetone alone (control) cells by one-way Anova (p<0.05) Published in 
Simonetti et al 2001 (213)
L
B. Long-term assays o f  chemical toxicity
(i) Colony-forming ability
Neither IX nor 10X DDE had an effect on the number of WS1 cells surviving to form 
colonies. There was no significant difference between the number o f colonies formed by 
WS1 cells treated with acetone alone (control), IX or 10X DDE, (control = 100% ±
3.8%, IX = 100.5% ± 2.5%, 10X = 98% ± 12.7%) (Figure 15). In contrast, both IX and 
10X DDE had a significant effect on the number of NIH 3T3 cells surviving to form 
colonies (p < 0.05). Treatment with both IX and 10X DDE resulted in a decrease in the 
number of colonies formed by NIH 3T3 cells, specifically, control = 100%± 5 .8%, IX = 
57%± 3.8% and 10X = 53% ± 13.4% with no significant difference in cell survival 
between the two DDE treatments (Figure 15).
(ii) Transformation assay
No significant difference was found between the number of foci formed by control (n =
39 ± 8.2) or DDE exposed NIH 3T3 cells treated with IX (n = 39 ± 4.6), 10X (n = 39 ± 
9.1) or 100X DDE (n = 38 ± 5.6) (Published in 213).
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Section II: Effects o f environmentally relevant concentration o f  p ,p  ’-DDE on mismatch 
repair rates at an oncogenic hotspot
A. Mismatch repair rates at codon 12 o f  H-ras in the presence o f  p ,p  '-DDE 
Mismatches at the middle base position of codon 12 H-ras (G:T and G:A) were 
introduced into WS1 and NIH 3T3 cells in the presence and absence o f DDE. These 
particular mismatches were chosen because they represent the best and worst repaired 
codon 12 mismatches in mammalian cells respectively (53). Extraction o f the plasmid 
DNA from NIH 3T3 cells and subsequent transformation of the mismatch deficient 
NR9374 bacteria with the extracted plasmid eliminated the problem of contaminating 
human genomic H-ras sequences from the WS1 cells. As well, cells were exposed to 10X 
DDE only, as this quantity represents the highest concentration found in Inupiat umbilical 
cord blood and in a sense the “worst case” scenario. It must be stressed that the results 
presented here are preliminary, due to small numbers, and it is difficult to draw firm 
conclusions from them. Further work is necessary for a more in-depth investigation of the 
effect of DDE exposure on mismatch repair in human and murine cells in culture.
WSJ cells: Shown in Table 8 are the results of this preliminary investigation into the 
effects of DDE on mismatch repair in WS1 human cells. DDE does not appear to have a 
discernable effect on the ability ofW Sl cells to correctly repair G:T mismatches (G:T ■+- 
DDE = 87%, G:T - DDE = 85%). However there appears to be a slight decrease in the
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Table 8: Mismatch repair at codon 12 o f H-ras in p,p’-DDE treated and untreated
WS1 cells
WS1 cells 
Mismatch 
and 
Treatment
Correctly repaired 
mismatch => G:C 
(Total Assayed)
Incorrectly 
Repaired 
Mismatch to 
T:A or A:T 
(Total Assayed
Unrepaired 
Mismatch => G:C / 
T:A or G:C / A T 
(Total Assayed)
G:T + p,p’-DDE 87% 4% 9%
(20/23) (1/23) (2/23)
G :T-p,p-D D E 85% 10% 5%
(17/20) (2/20) (1/20)
G:A + p,p’-DDE 93% 0% 7%
(14/15) (0/15) (1/15)
G:A -  p.p’-DDE 67% 0% 33%
(6/9) (0/9) (3/9)
amount o f G:T mismatch that is incorrectly repaired (resulting in activating mutation) in 
DDE exposed cells as compared to unexposed WS1 cells (G:T + DDE = 4%, G:T -  DDE 
=  10% ).
In contrast, WS1 cells treated with DDE exhibit a much improved repair o f the 
G: A mismatch as compared to untreated cells (G: A + DDE = 93%, G:A -  DDE = 67%) 
(Table 8). There is also a concomitant decrease in the amount of G:A mismatch left un­
repaired in DDE treated cells as compared to unexposed WS1 cells (G:A + DDE 7%,
G:A -  DDE = 33%).
NIH 3T3 cells: Mismatch repair rates for NIH 3T3 cells treated with and without 10X 
DDE are shown in Table 9. DDE treatment has no apparent effect on the ability o f NIH 
3T3 cells to repair G:T mismatches, as both treated and un-treated cells repair G:T with 
100% efficiency.
In contrast, DDE treated cells show a slight increase in the amount of G:A 
mismatch that is correctly repaired (G:A + DDE = 89%, G:A -  DDE = 80%) (Table 9). 
NIH 3T3 cells also exhibit a slight decrease in the amount of G:A mismatch that remains 
un-repaired while the cells are exposed to DDE (G:A + DDE = 0%, G:A - DDE = 10%) 
with no substantial difference between treated and un-treated cells in the amount of 
mismatch that is repaired incorrectly and results in an activating mutation.
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Table 9: Mismatch repair at codon 12 of H-ras in p,p'-D DE treated and untreated
NIH 3T3 cells
NIH 3T3 cells
Mismatch
and
Treatment
Correctly repaired 
mismatch => G:C 
(Total Assayed)
Incorrectly 
Repaired 
Mismatch to 
T:A or A:T 
(Total Assayed
Unrepaired 
Mismatch => G:C / 
T A or G:C / A:T 
(Total Assayed)
G:T + p,p’-DDE 100% 0% 0%
(10/10) (0/10) (0/10)
G :T -p ,p ’-DDE 100% 0% 0%
(8/8) (0/8) (0/8)
G:A + p,p’-DDE 89% 11% 0%
(16/18) (2/18) (0/18)
G:A -  p,p’-DDE 80% 10% 10%
(8/10) (1/10) (1/10)
IV. DISCUSSION
PART I: Mismatch repair at an oncogenic hotspot in Gi synchronized NIH 3T3 ceils 
Since the discovery o f the mismatch repair system in E.coli it has been considered 
primarily if not exclusively a post-replication DNA repair mechanism and, due to their 
similarities, the prokaryotic and eukaryotic mismatch repair systems were assumed to 
function within a similar timeframe. Therefore, with respect to the mammalian cell cycle, 
this would mean that the mismatch repair system would be most active in the G2 phase of 
the cell cycle immediately following DNA replication (107, 247, 248). However, as 
discussed in the introduction, mismatches can occur throughout the cell cycle by a variety 
of processes, with failure to repair these lesions before DNA replication resulting in 
mutation fixation. As we know, faithful replication of DNA is o f paramount importance 
for the maintenance of genomic integrity, therefore, we postulated that mismatch repair 
would be active during the Gi phase o f the mammalian cell cycle in order to ensure that 
DNA damage is repaired before DNA replication takes place. Indeed, results presented 
here show that repair of base:base mismatches at the codon 12 H-ras oncogenic hotspot is 
active and accurate during the Gi phase of the mammalian cell cycle (Table 4). We have 
also shown that the Epstein-Barr virus derived p220.pbc plasmid replicates 
synchronously with the cell cycle in murine cells (Figure 8). In addition, the mismatch 
repair protein MSH2 was found in both cytoplasmic and nuclear extracts from Gi 
synchronized cells and in relatively equal amounts as compared to extracts from non- 
synchronized cell cultures (Figure 9).
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As discussed above a main goal o f this study has been to determine whether the 
DNA mismatch repair system is active during the Gi phase of the mammalian cell cycle. 
Using methods previously tested, single base:base mismatches were constructed at the H- 
ras codon 12 oncogenic hotspot and subsequently introduced into Gi synchronized 
mammalian cells in culture. However, in order to study mismatch repair in synchronized 
cell populations several challenges had first to be overcome.
Firstly, a method had to be found that would synchronize large populations of 
NIH 3T3 cells in the Gi phase of the cell cycle. Several synchronization methods exist for 
mammalian cells in culture (250). For example, drug treatments such 
as hydroxyurea, aphidicolin, thymidine and most recently, lovastatin, have been used to 
produce large populations o f synchronous cells. However, treatment with these drugs can 
result in DNA damage or impaired cell function (251, 252, 253, 254, 255). As well, 
serum starvation has been used successfully as a means for achieving cell cycle 
synchronization in many cell types including NIH 3T3 fibroblasts (211, 235, 236, 256).
For exponential growth NIH 3T3 fibroblasts require exogenously added growth 
factors, usually supplied by supplementation of the growth medium with 10% serum. On 
serum withdrawal, these cells undergo growth arrest and remain in a quiescent state 
termed Gi. However, when stimulated with fresh serum the cells synchronously re-enter 
the cell cycle and engage in exponential growth with no apparent detrimental effects on 
cell function (257). Consequently we employed the method of serum starvation to 
achieve Gi synchronous populations o f cells. Indeed, our results show that over 96% of 
cells were arrested in Gi by the third day of serum starvation (Table 3). Furthermore
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greater than 96% of these cells remained in Gi for up to 12 hours after media replacement 
after which time the cells began to re-enter the cell cycle (Table 3). The 12-hour delay in 
cell cycle progression provided sufficient time for transfection of the mismatched 
plasmid (4 hours, see materials and methods) and provided an additional 7-hour period 
for repair to occur before the cells entered the DNA synthesis phase of the cell cycle.
The second challenge of this study concerned replication kinetics of the 
mismatched plasmid vector. In order to ensure accurate results, it was important to 
document that the plasmid replicated synchronously with the cell cycle. Plasmid vectors 
based on the Epstein-Barr virus (EBV) origin of replication are maintained as 
extrachromosomal plasmids and replicate once per cycle at high efficiency in human and 
simian cells (258), however, no similar information exists as to how these plasmids 
behave in murine cells. Therefore we examined the replication kinetics of the wild-type 
p220.pbc EBV derived plasmid in Gi synchronized NIH 3T3 cells. We have successfully 
shown that replication of the p220.pbc plasmid is substantially delayed in Gi 
synchronized NIH 3T3 murine cells when compared to non-synchronized control cells 
(Figure 8) indicating that the p220.pbc plasmid replicates synchronously with the murine 
cell cycle.
Lastly, as discussed in the introduction, mismatch repair is not the only DNA 
repair mechanism capable of repairing mismatches. For example, the BER enzyme 
thymine DNA glycosylase can remove thymine from G:T mispairs (73, 74, 75, 76). 
Therefore, for additional evidence of mismatch repair activity we examined Gi nuclear 
and cytoplasmic extracts for the presence of the MSH2 mismatch repair protein
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(reviewed in introduction, part I). Our results clearly show that the MSH2 protein is 
found in both NIH 3T3 cytoplasmic and nuclear Gi extracts and that it is present in 
relatively equal amounts in extracts from both synchronized and non-synchronized cells 
(Figure 9). These results agree with those o f Meyers et al 1997 who found that, in human 
fibroblasts, the levels of hMSH2 mRNA and protein did not change throughout the cell 
cycle (211). Our data indicates that in NIH 3T3 cells at least one of the mismatch repair 
proteins responsible for the detection and repair o f mismatched DNA is present in the Gi 
phase o f the cell cycle.
As a result of the experiments described above, we have successfully 
demonstrated; (1) serum starvation is a successful and non-toxic method to achieve Gi 
synchrony in large populations of NIH 3T3 cells; (2) the p220.pbc plasmid replicates 
synchronously with the murine cell cycle; and (3) the MSH2 mismatch repair protein is 
present in Gi cells indicating potential mismatch repair activity in Gi. Based on this 
information we then proceeded to examine mismatch repair activity in the Gi phase of the 
mammalian cell cycle.
Our results for mismatch repair at the middle nucleotide hotspot of codon 12 in 
Gi-synchronized cells demonstrate that repair o f mismatched DNA is active in the G] 
phase o f the mammalian cell cycle (Table 4). Furthermore, we have observed correct 
repair o f virtually all codon 12 mismatches transfected into G|-synchronized cells, with 
the single exception of one incorrectly repaired G:T mismatch resulting in an activating 
mutation. Interestingly, this was the first time that we observed a mutated sequence at
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codon 12 that did not result from replication before repair, which would have been 
indicated by a mixed sequence at this site (53, 54, 234).
Previously, we and other researchers have found that, when compared to other base:base 
mismatches, the G:T mismatch is repaired with highest efficiency in E.coli, murine and 
simian cells (53, 54, 234, 258). We believe that the reason for this is because several 
systems exist to repair G:T mismatches and the combined action o f these systems results 
in extremely efficient repair. For example, in addition to the mismatch repair system, the 
BER thymine DNA glycosylase enzyme can repair G:T mismatches resulting either from 
misincorporation during DNA synthesis or deamination o f 5-methylcytosine (73, 74. 75, 
76). Several investigators have found that expression o f the glycosylase enzymes is 
regulated during the cell cycle with the highest protein levels measured prior to DNA 
synthesis which corresponds to late Gi phase (260, 261, 262, 263, 264, 265). Therefore, 
we spectulate that the G:T incorrect repair we observed was due to the down regulation 
of the BER enzyme during earlyGi phase of the cell cycle in NIH 3T3 cells. However, we 
must remember that the mutation observed represents one sample whose incorrect repair 
could be due to a number of, as yet, unexplained reasons.
In contrast, we found a much improved repair rate for the three remaining 
mismatches as compared to repair rates in non-synchronized cells (Figure 10) We 
previously found high rates of unrepaired mixtures at codon 12 in non-synchronized 
cells, which, we believe, resulted from plasmid replication before repair could take place 
(53. 234). Although it is theoretically possible that the increased correct mismatch repair 
rate observed in Gi synchronized cells is due to increased fidelity o f  repair during the Gi
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phase of the cell cycle, this seems unlikely. At best we would expect that the repair rate 
in Gi would be similar to that for non-synchronized cells. Our FACS analysis results 
have shown that >96% of cells are in Gi for as long as 7 hours after completion of 
transfection. Therefore, the increased correct mismatch repair rate during Gi probably 
indicates a function of increased time for repair activity. Nevertheless, these results 
demonstrate that the mismatch repair system is active during the Gi phase of the cell 
cycle and in addition, these results also provide some insight into mechanisms of repair at 
mutagenic hotspots throughout the cell cycle.
The reasons for the occurrence of mutagenic hospots, such as codon 12 of H-ra.v, 
remain unclear and the hypotheses put forward to explain them have been previously 
discussed (see introduction part 1). One of these hypotheses states that there is decreased 
fidelity of repair or inefficient repair at particular sequences. For example, primer 
extension studies have demonstrated that both DNA polymerases a  and P have a strong 
pause site at the nonmutated codon 12 location, suggesting stearic hindrance, a difficulty 
in the gap filling stage o f the DNA repair process or a general difficulty in enzymatic 
reactions at this site (266). In addition, previous studies from this laboratory have found 
that mismatches at the middle nucleotide position of codon 10 H-ras in non-synchronized 
cells are repaired significantly more efficiently than when located at the codon 12 hotspot 
(54). Furthermore, gel-shift experiments have found mismatch specific binding to 
oligonucleotides containing mismatches at codon 10 but not to the same oligonucleotides 
containing mismatches at codon 12 (54).
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These results suggest cellular deficiencies in the recognition o f specific 
mismatches that in proliferating cells result in low levels of repair. However, the Gi 
mismatch repair results presented here demonstrate that, given sufficient time before 
DNA replication, a mammalian cell can repair mismatches at an oncogenic hotspot with 
high efficiency Therefore these results lend weight to the argument that mismatch repair 
is inefficient rather than inaccurate. Furthermore, repair is inefficient due to a rate- 
limiting step in the repair process that results in replication of the DNA before repair can 
take place.
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PART II: Effects o f  p ,p ’-DDE on cell toxicity and mismatch repair ability at an 
oncogenic hotspot
This study demonstrates that DDE, at levels measured in the umbilical cord blood of 
Alaskan Inupiat newborns, does have significant effects on embryonic human and murine 
fibroblast cells in culture. The specific effects, discussed below, occur when cell cultures 
are exposed to concentrations of DDE that are environmentally relevant and are 
significantly lower than the concentrations used in all other published DDE toxicology 
studies. Results of the DABA assay for changes in cell number (Figure 11) suggest that 
these low concentrations of DDE caused NIH 3T3 and WS1 cell numbers to decrease 
within a few hours of exposure. Subsequent assays revealed that IX and 10X DDE were 
cytotoxic to the NEH 3T3 embryonic mouse fibroblast cell line and consequently 
decreased overall long-term survival. However, DDE treatment had an entirely different 
effect on the WS1 human embryonic cell, in that exposure caused a pause in the cell 
cycle, which subsequently resulted in an increase in the correct rate of mismatch repair at 
the codon 12 H-ras oncogenic hotspot. This result, although surprising, is in agreement 
with our previous results from Gi synchronized cells, in which we have found that 
increased time for repair results in a much improved repair rate. In addition, exposure to 
DDE had no apparent long-term effects on WS1 cell survival (Figures 14B and 15).
A modification of the DABA assay (240) was used to determine cell number at 
specific intervals after the initiation of chemical exposure. We have used this assay 
extensively and have found it to be an extremely reliable and sensitive method for 
detecting small changes in cell numbers over relatively short periods of time. Initial
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experiments, performed to elucidate if short-term DDE exposure resulted in detectable 
changes in cell number, revealed that both NIH 3T3 and WS1 cells were affected within a 
similar time period by DDE (Figure 11). Furthermore, both cell types eventually 
recovered from the initial decrease in cell number and all treated samples attained cell 
numbers similar to controls when confluence had been reached and the cells had ceased 
to grow.
A decreased number of cells in the DDE treated plates could be the result of cell 
death, since dead cells detach from the plate and are washed away in the initial steps of 
the harvesting procedure. Another possible explanation for fewer cells per plate is an 
arrest in the cell cycle. In this scenario, although cells are not physically lost from the 
plate, a pause in the initial stages of the cell cycle, before DNA replication, would result 
in a lower cell number when compared to controls assayed at the same time-point. These 
initial experiments, in addition to demonstrating a toxic effect of DDE, also provided an 
indication o f the time period within which the measured effects occurred for each cell 
type.
NIH 3T3 cells: Cell viability, as determined by the trypan blue assay, revealed 
that exposure to both IX and 10X DDE resulted in significant NIH 3T3 cell death within 
2-4 hours o f treatment, as compared to control cells (Table 6). Cell death in NIH 3T3 
cells occurred within the same time period at which the DABA assay demonstrated an 
initial decrease in cell number for both IX and 10X DDE treatments (Figure 1 1A).
Comet assay results presented in Table 7 indicate that IX and 10X DDE caused a 
significant amount of strand breaks in the DNA of NIH 3T3 cells. The DNA strand
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breaks could be the result o f a direct interaction between the chemical and nuclear DNA. 
As well, an increase in intracellular reactive oxygen species and the release o f clastogenic 
elements (both possible consequences o f DDE's action) and/or attempts to repair the 
damage caused by these agents could cause DNA strand breaks. Alternatively, it is also 
possible that the strand breaks found in NIH 3T3 cells were due to the DNA degradation 
that occurs during cell death. Results o f the focus-forming assay revealed that up to 100X 
DDE (35|ig/l) (see results) had no apparent mutagenic effect on the transforming 
potential of NIH 3T3 cells. Previous use of this assay by our laboratory has resulted in a 
several fold increase in the number o f transformed foci formed by NIH 3T3 cells 
transfected with mutated Yl-ras (234). This information, along with the results of the 
trypan blue assay (Table 6), suggest that the DNA strand breaks observed in the comet 
assay are either the result of cell death or occur by some other mechanism.
As part of this investigation we determined if DDE treatment had any detectable 
effect on total glutathione concentration (GSH + GSSG) and/or the amount of glutathione 
in the reduced state (GSH). DDE is a lipophilic compound and as such, primarily targets 
the lipid rich plasma and organellar membranes (267). DDE has been found to modify 
basic membrane mechanisms, such as permeability to non-electrolytes and cation 
transport, through a physical interaction with the lipid bilayer (268). Glutathione has been 
implicated in a variety of cellular processes including detoxification o f numerous 
electrophilic substances and peroxides, control of enzyme activity, regulation of the cell 
cycle and apoptosis (269, 270, 271, 272, 273).
Within the normal limits o f cellular redox activity glutathione levels are 
maintained by a complex mechanism involving control of synthesis, transport and 
utilization (271, 272). However, glutathione levels have been found to fluctuate in 
response to a variety of cellular insults. For example, oxidative stress, which can 
originate from a variety o f exogenous and endogenous sources, can produce a decrease in 
glutathione levels (274, 275, 276). Conversely, similar types of oxidative stress have been 
found to up-regulate the transcription of at least one of the enzymes involved in 
glutathione synthesis resulting in an increase in cellular glutathione levels (276, 277). As 
well, oxidation of reduced glutathione has been shown to occur during apoptosis resulting 
in decreased reduced glutathione levels (269).
It is possible that the increased membrane fluidity, induced by DDE, could result 
in the leakage of oxygen radicals out of the mitochondria and the increased movement of 
potentially damaging agents across the plasma membrane into the cell Both of these 
processes would increase oxidative stress, initially depleting glutathione but in the 
process initiating the up-regulation o f glutathione production, cumulating in an increase 
in total glutathione levels.
In NIH 3T3 cells DDE treatment does not alter total glutathione levels but does 
cause alterations in reduced glutathione levels (Figure 12A and 12C). The large increase 
in reduced glutathione in NIH 3T3 cells treated with the IX concentration for 4 hours 
suggests an inductive response to DDE exposure (Figure 12C). We were unable to 
determine GSSG concentrations in these samples, therefore the increase in GSH may 
reflect a concomitant decrease in GSSG (which would not affect total glutathione levels)
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or may simply reflect differences in the sensitivity of the two assays. The significant 
decrease o f reduced glutathione at 2 hours of 10X DDE exposure may have been caused 
by the immediate and uncompensated oxidation o f GSH to GSSG in response to the 
chemical insult.
The cell cycle kinetic analysis results demonstrate that NTH 3T3 progression 
through the cell cycle is unaffected by either IX or 10X DDE treatments (Figure 14A). 
Chemical toxicity, as determined by NIH 3T3 colony-forming ability, did occur as 
exposure to both IX and 10X DDE resulted in similarly decreased long-term survival of 
NIH 3T3 ceils (Figure 15).
In addition, preliminary experiments to investigate the effect of DDE on DNA 
mismatch repair at an oncogenic hotspot were performed. No difference was observed in 
the repair rate of G:T mismatches regardless o f the cellular exposure to DDE (Table 9). 
This is in agreement with previous studies from our laboratory in which we found that 
G:T mismatches were also repaired with 100% efficiency in NIH 3T3 cells (53, 234). In 
contrast, there was a slight increase in the amount of G:A mismatch that was correctly 
repaired in DDE treated cells, perhaps reflecting a cell cycle pause too short to be 
detected by FACS analysis (Table 9).
Our previous results have shown that the G:A mismatch is repaired with the 
poorest efficiency in proliferating NIH 3T3 cells (35%) with the majority o f the 
mismatch being left unrepaired (53). The p220.pbc plasmid used in previous studies is 
capable o f replication in mammalian cells with the result that unrepaired mismatch is 
represented by mixtures of mutated and wildtype sequences in the final analysis.
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However, the pbc-N 1 plasmid used in the DDE experiments cannot replicate in 
mammalian cells and therefore unrepaired mismatch remains in the cell. Perhaps it is due 
to the lack of plasmid replication and thus increased time o f exposure to the DNA repair 
machinery that we see a much improved repair rate o f G: A mismatches in both DDE 
treated and untreated NIH 3T3 cells. Interestingly, for the first time we found G:A 
mismatch which was incorrectly repaired to an activating mutation, in both DDE, treated, 
and untreated cells (Table 9).
The reasons for the incorrect repair of the G:A mismatch remain unclear but may 
possibly be due to its location at the H-ras codon 12 oncogenic hotspot, the mismatch 
itself or a combination o f these factors. Other investigators have found the G:A mismatch 
to be particularly difficult to repair in both in vivo and in vitro repair studies regardless of 
its location (259, 278, 279). Perhaps the G:A mismatch coupled with its codon 12 
location presents a particularly difficult repair scenario. Lack of repair of G A 
mismatches may be biologically relevant as the resulting T A transversion is a common 
activating mutation found at this codon 12 H-ras location in naturally occurring tumors 
(36, 37, 38, 39). Obviously further studies are needed to examine and compare repair 
rates at non-oncogenic hotspots such as codon 10 W-ras with the non-replicating plasmid. 
Such studies, at the very least, might help determine whether the G:A mismatch or its 
codon 12 location are primarily responsible for the incorrect repair found in this study.
Together, the results of these assays indicate that DDE, at both IX (0.35|ig/l) and 
10X (3.5^g/l) concentrations, caused sufficient cell death o f NIH 3T3 cells within the 
first hours of exposure to decrease overall long-term survival. Cell death may be due to
excessive DNA damage, the presence of which is indicated by the Comet assay, or some 
other mechanism of cell toxicity. Despite the use of several commercially available 
assays to determine whether cell death occurred by apoptosis or necrosis, it has not yet 
been possible to definitively identify which death process occurs in NIH 3T3 cells 
exposed to DDE. We suspect that the ambiguous results obtained with these assays are 
due, in part, to the membrane effects of DDE. We are currently investigating other 
methods of apoptosis /necrosis detection, which do not require the use of membrane, 
bound dyes. In addition, the classical DNA laddering effect, observed by agarose 
electrophoresis, caused by apoptosis cannot be used with NIH 3T3 cells because of their 
aneuploid nuclear DNA.
WSJ cells: In contrast, results from the above assays indicate that exposure to 
these low concentrations o f DDE has an entirely different effect on WS1 cells. The 
findings of the trypan blue and Comet assays (Tables 6 and 7) indicate that neither IX or 
10X DDE caused cell death or significant DNA damage in WS1 cells. Therefore, the 
decrease in cell number observed in the DABA assay does not appear to be the result of 
cell death but must occur by another mechanism discussed below (Figure 1 IB).
Both IX and 10X DDE caused significant alterations in the total glutathione 
levels ofW Sl cells (Figure 12B). The significant increase in WS1 total glutathione level 
at 4 hours exposure to IX DDE is most likely the result o f up-regulation of glutathione 
synthesis. In addition, it has been reported that increased glutathione levels are associated 
with release from cell cycle arrest (273, 280, 281). Since the cell cycle kinetic results 
(discussed below) indicate a cell cycle arrest, this could account for the fluctuating total
glutathione levels. The initial significant decrease in total glutathione levels at 2 hours 
exposure to 10X DDE likely indicates that both GSH and GSSG are leaking out of the 
cells through damaged membranes. The initial loss of total glutathione could then trigger 
increased synthesis as is evident by the 4 hour and 6 hour stepwise increase o f total 
glutathione (Figure 12B).
GSH levels exhibit a similar fluctuating pattern in both 1X and 1 OX DDE treated 
cells. The initial increase after 2 hours o f exposure for both DDE treatments may indicate 
a cellular response that includes up-regulation of GSH production. The subsequent 
decrease in reduced glutathione levels by 4 hours for both treatments, suggests that GSH 
is undergoing oxidation to GSSG in direct response to the oxidative stress caused by the 
interaction of DDE with cellular membranes. As well, increased amounts of GSH, by 6 
hours exposure to both DDE concentrations corresponds with the increased 4 and 6 hour 
total glutathione levels (Figure 12B).
Cell cycle kinetic analysis revealed that WS1 cells treated with IX DDE 
experience a delay or arrest of at least two hours, in the initiation of BrdU incorporation, 
as compared to controls (Figure 14B). This delay/arrest occurs at approximately the same 
time as a decrease in cell number is observed and is indicative of a pause or arrest in the 
cell cycle (Figure 1 IB). As well, the observed increase in WS1 total glutathione level 
occurs at approximately the same time that these cells begin to re-enter the cell cycle 
(Figure 12B).
The results of the colony-forming assay indicate that W S1 cell survival is not 
affected by long-term exposure to either IX or 10X DDE (Figure 15). Together with the
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findings presented above it appears that the decrease in WS1 ceil number observed for 
both DDE concentrations is not due to cell death, but to a delay or a short recoverable 
arrest in the cell cycle. It is possible that this cell cycle delay/arrest provides the time 
necessary to counteract the effects o f these low environmental concentrations o f DDE 
without compromising the long-term survival o f the cell.
Mismatch repair rates at an oncogenic hotspot in WS1 cells in the presence and 
absence o f DDE were also examined (Table 8). As was the case with the NIH 3T3 cells, 
DDE exposure did not appreciably change the correct repair rates of the G:T mismatch.
In contrast, dramatic results were found when the repair rate of the G:A mismatch was 
examined. Exposure ofW Sl cells to DDE resulted in a 26% increase in the correct repair 
of G:A mismatches back to the wildtype G:C sequence. We suspect that this increased 
repair rate was facilitated by the cell cycle arrest induced by DDE in these cells (Figure 
14B). As described earlier, the plasmid used in these mismatch studies does not replicate 
in mammalian cells, therefore, the improved repair rate of the G:A mismatch can not be 
due to repair before replication as was the case in the study of mismatch repair in the Gi 
phase o f the cell cycle described in Part I. However, in addition to providing time for 
repair, cell cycle arrests can also result in the induction of DNA damage repair enzymes 
(206, 207). Therefore, we postulate that the improved repair rate seen in the WS1 cells 
exposed to DDE occurs as a direct consequence of the induction of repair enzymes by the 
cell cycle arrest machinery.
It is unclear why we find so much unrepaired G:A mismatch in the DDE untreated 
WS1 cells (33%). However, as was the case with the NIH 3T3 cells, this may be due to
the repair difficulties presented by this particular mismatch in combination with its 
location at the codon 12 hotspot. Further studies that examine repair rates at a non- 
oncogenic hotspot with this non-replicating plasmid would help determine the roles 
played by both the codon 12 location and the mismatch combination in the incorrect 
repair found in these studies.
Interestingly, in all but the glutathione assay, we found no significant difference 
between the effects of IX and 10X DDE. Also, the effects o f DDE on both cell types, 
although different, occurred soon after the initiation of DDE treatment and did not 
increase in severity with long-term exposure. It has been reported that artificial vesicles 
can absorb up to several hundred times the equivalent o f the 10X DDE concentration 
used in these studies without affecting the integrity o f the membrane (267). Therefore, 
lack o f a difference in effect between IX and 10X DDE may be due to the ability o f the 
cellular membrane to absorb and sequester these relatively small amounts of DDE
This study has also demonstrated that two immature mammalian cell types can 
have significantly different cellular responses to the same exposure levels of a single 
chemical. DDE exposure at both IX and 10X concentrations resulted in significantly 
increased NIH 3T3 cell death, DNA damage either prior to or due to cell death, altered 
reduced glutathione levels and decreased long-term cell survival, but had no effect on cell 
cycle kinetics or DNA mismatch repair abilities. Conversely, DDE treatment of WS1 
cells at identical concentrations and times of exposure did not cause cell death, DNA 
damage, decrease cell viability, or affect long-term cell survival, but did alter the levels
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of both total and reduced glutathione, affected progression through the cell cycle and, 
most significantly actually improved mismatch repair rates at an oncogenic hotspot.
The most striking difference between the responses o f the two cell types is that 
WS1 cells respond to DDE exposure with a delay or an arrest in their cell cycle, whereas 
the cell cycle o f NIH 3T3 cells is unaffected by DDE treatment. We therefore conclude 
that the NIH 3T3 cell death that occurred during exposure to DDE, was not due to the 
direct effects o f the chemical, but rather occurred due to this cell type’s inability to arrest 
its cell cycle and thus respond appropriately to the damage caused by DDE. In contrast, 
because WS1 cells have the ability to delay/arrest the cell cycle they did not suffer the 
same cytotoxic consequences when exposed to DDE. However, the cell cycle arrest may 
have serious consequences for a developing embryo, as normal development requires 
precisely timed cellular proliferation and differentiation events (282, 283).
The results of this study demonstrate that DDE, at concentrations relevant to the 
Alaskan environment, has detectable effects on embryonic mammalian cells in culture. 
Furthermore, DDE has specific effects on human and mouse embryonic fibroblasts, 
which lack a mature hepatic cell’s capacity to significantly metabolize the chemical to a 
more or less toxic compound. Finally, the results of this study emphasize the importance 
of further investigations to determine the effects of DDE on the sensitive systems of the 
developing embryo, such as the immune, endocrine, hepatic and central nervous system.
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